Professor John E Brazier

All publications

Books

• Brazier J, Ratcliffe J, Saloman J & Tsuchiya A (2016) Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press.
• Brazier JE, Ratcliffe J, Tsuchiya A & Salomon J (2007) Measuring and Valuing Health Benefits for Economic Evaluation. Oxford: Oxford University Press.
• Brazier JE, Stevens A, Abrams K, Fitzpatrick R & Lilford R (2001) Methods in Health Technology Assessment. London: Sage Books.
• Brazier JE, Black N, Fitzpatrick R & Reeves B (1999) Methods for Health Services Research: a state of the art guide.. London: BMJ Books.

Journal articles

• Acaster S, Mukuria C, Rowen D, Brazier J, Wainwright C, Quon B, Duckers J, Quittner A, Lou Y, Sosnay P & McGarry L (2022) Development of the CFQ-R-8D: estimating utilities from the cystic fibrosis questionnaire-revised. Value in Health. View this article in WRRO
• Powell PA, Karimi M, Rowen D, Devlin N, van Hout B & Brazier JE (2022) Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences. Quality of Life Research. View this article in WRRO
• Broderick L, Bjorner JB, Lauher-Charest M, White MK, Kosinski M, Mulhern B & Brazier J (2022) Deciding Between SF-6Dv2 Health States: A Think-Aloud Study of Decision-Making Strategies Used in Discrete Choice Experiments. Value in Health.
• Broderick L, Bjorner JB, Lauher-Charest M, White MK, Kosinski M, Mulhern B & Brazier J (2022) Development of the SF-6Dv2 health utility survey : comprehensibility and patient preference. Journal of Patient-Reported Outcomes, 6(1).
• Brazier J, Peasgood T, Mukuria C, Marten O, Kreimeier S, Luo N, Mulhern B, Pickard AS, Augustovski F, Greiner W , Engel L et al (2022) The EQ Health and Wellbeing: Overview of the Development of a Measure of Health and Wellbeing and Key Results. Value in Health.
• Carlton J, Peasgood T, Mukuria C, Connell J, Brazier J, Ludwig K, Marten O, Kreimeier S, Engel L, Belizán M , Yang Z et al (2022) Generation, selection, and face validation of items for a new generic measure of quality of life : the EQ Health and Wellbeing. Value in Health. View this article in WRRO
• Schneider P, van Hout B, Heisen M, Brazier J & Devlin N (2022) The Online Elicitation of Personal Utility Functions (OPUF) tool: a new method for valuing health states [version 1; peer review: 1 approved]. Wellcome Open Research, 7. View this article in WRRO
• Peasgood T, Mukuria C, Brazier J, Marten O, Kreimeier S, Luo N, Mulhern B, Greiner W, Pickard AS, Augustovski F , Engel L et al (2022) Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ Health and Wellbeing. Value in Health.
• Mukuria C, Connell J, Carlton J, Peasgood T, Scope A, Clowes M, Rand S, Jones K & Brazier J (2022) Qualitative Review on Domains of Quality of Life Important for Patients, Social Care Users, and Informal Carers to Inform the Development of the EQ Health and Wellbeing. Value in Health.
• Mulhern B, Norman R & Brazier J (2021) Valuing SF-6Dv2 in Australia using an international protocol. PharmacoEconomics, 39(10), 1151-1162.
• Shah KK, Bennett B, Lenny A, Longworth L, Brazier JE, Oppe M, Pickard AS & Shaw JW (2021) Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms. The European Journal of Health Economics.
• Broderick L, Bjorner J, Lauher M, Kosinski M, White MK, Mulhern B & Brazier JE (2021) PNS111 Development of the SF-6DV2 Health Utility Survey: Content Validity and Patient Preference. Value in Health, 24, S193-S193.
• McDool E, Mukuria C & Brazier J (2021) A comparison of the SF-6Dv2 and SF-6D UK utility values in a mixed patient and healthy population. PharmacoEconomics. View this article in WRRO
• King MT, Norman R, Mercieca-Bebber R, Costa DSJ, McTaggart-Cowan H, Peacock S, Janda M, Müller F, Viney R, Pickard AS , Cella D et al (2021) The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set. Value in Health.
• Pennington R, Alshreef A, Flight L, Metry A, Poku E, Hykin P, Sivaprasad S, Prevost AT, Vasconcelos JC, Murphy C , Kelly J et al (2021) Cost effectiveness of ranibizumab vs aflibercept vs bevacizumab for the treatment of macular oedema due to central retinal vein occlusion: the LEAVO study. PharmacoEconomics. View this article in WRRO
• Zoratti MJ, Pickard AS, Stalmeier PFM, Ollendorf D, Lloyd A, Chan KKW, Husereau D, Brazier JE, Krahn M, Levine M , Thabane L et al (2021) Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists.. Eur J Health Econ.
• Terheyden JH, Behning C, Lüning A, Wintergerst L, Basile PG, Tavares D, Melício BA, Leal S, Weissgerber G, Luhmann UFO , Crabb DP et al (2021) Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study. BMC Medical Research Methodology, 21.
• Wu J, Xie S, He X, Chen G, Bai G, Feng D, Hu M, Jiang J, Wang X, Wu H , Wu Q et al (2021) Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension. PharmacoEconomics.
• Keetharuth D, Rowen D, Bjorner J & Brazier J (2021) Estimating a preference-based index for mental health from the recovering quality of life measure: valuation of recovering quality of life utility index. Value in Health, 24(2), 281-290. View this article in WRRO
• Finch AP, Brazier J & Mukuria C (2021) Selecting bolt-on dimensions for the EQ-5D: testing the impact of hearing, sleep, cognition, energy, and relationships on preferences using pairwise choices. Medical Decision Making, 41(1), 89-99. View this article in WRRO
• Scarisbrick J, Schmidt F, Turini MM, D'agostino P, Thornton S, Evans J, Ader J, van Hest N & Brazier JE (2020) PRO140 Health-Related Quality of Life Associated with Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma Patients: Determination of Utility Values from a UK-Based Clinician Questionnaire. Value in Health, 23, S715-S715.
• Shah K, Bennett B, Lenny A, Longworth L, Brazier JE, Oppe M, Pickard AS & Shaw JW (2020) PCN48 Adapting Preference-Based Utility Measures to Capture the Impact of Cancer Treatment-Related Symptoms. Value in Health, 23, S430-S430.
• Di Tanna GL, Urbich M, Wirtz HS, Potrata B, Heisen M, Bennison C, Brazier J & Globe G (2020) Health state utilities of patients with heart failure: a systematic literature review. PharmacoEconomics. View this article in WRRO
• Xie S, Wu J, He X, Chen G & Brazier JE (2020) Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? Evidence from SF-6Dv2 in China. Value in Health, 23(10), 1391-1399.
• Terheyden JH, Holz FG, Schmitz-Valckenberg S, Lüning A, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A , Sánchez CI et al (2020) Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR. Trials, 21(1).
• Peasgood T, Bhardwaj A, Brazier JE, Biggs K, Coghill D, Daley D, Cooper CL, De Silva C, Harpin V, Hodgkins P , Nadkarni A et al (2020) What Is the health and well-being burden for parents living with a child with ADHD in the United Kingdom?. Journal of Attention Disorders. View this article in WRRO
• Pennington BM, Hernández-Alava M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J (2020) Mapping from visual acuity to EQ-5D, EQ-5D with vision bolt-on, and VFQ-UI in patients with macular edema in the LEAVO trial. Value in Health. View this article in WRRO
• Brazier J, Mulhern B, Bjorner JB, Gandek B, Rowen D, Alonso J, Vilagut G & Ware J (2020) Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Medical Care, 58(6), 557-565. View this article in WRRO
• Mulhern BJ, Bansback N, Norman R & Brazier J (2020) Valuing the SF-6Dv2 classification system in the United Kingdom using a discrete-choice experiment with duration. Medical Care. View this article in WRRO
• Ara R, Hill H, Lloyd A, Woods HB & Brazier J (2020) Are current reporting standards used to describe health state utilities in cost-effectiveness models satisfactory?. Value in Health, 23(3), 397-405. View this article in WRRO
• Kharroubi SA, Beyh YS, Brazier J & Yang Y (2020) Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework. Quality of Life Research. View this article in WRRO
• Kharroubi S, Beyh Y, El Harake M, Dawoud D, Rowen D & Brazier J (2020) Examining the feasibility and acceptability of valuing the Arabic version of SF-6D in a Lebanese population. International Journal of Environmental Research and Public Health, 17(3). View this article in WRRO
• Wu J, Xie S, He X, Chen G & Brazier JE (2020) The simplified Chinese version of SF-6Dv2 : translation, cross-cultural adaptation and preliminary psychometric testing. Quality of Life Research. View this article in WRRO
• Norman R, Mercieca-Bebber R, Rowen D, Brazier J, Cella D, Pickard AS, Street DJ, Viney R, Revicki D & King M (2019) UK utility weights for the EORTC QLU-C10D. Health Economics, 28(12), 1385-1401. View this article in WRRO
• Meier P, Purshouse R, Bain M, Bambra C, Bentall R, Birkin M, Brazier J, Brennan A, Bryan M, Cox J , Fell G et al (2019) The SIPHER consortium : introducing the new UK hub for systems science in public health and health economic research. Wellcome Open Research, 4. View this article in WRRO
• Karimi M, Brazier J & Paisley S (2019) The effect of reflection and deliberation on health state values : a mixed-methods study. Value in Health. View this article in WRRO
• Poder TG, Fauteux V, He J & Brazier JE (2019) Consistency between three different ways of administering the Short Form 6 Dimension version 2. Value in Health, 22(7), 837-842. View this article in WRRO
• Matza LS, Brazier JE, Stewart KD, Pinto L, Bender RH, Kircik L, Jordan J, Kim KJ, Mutebi A, Viswanathan HN & Menter A (2019) Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI). Journal of Medical Economics. View this article in WRRO
• Mukuria C, Rowen D, Harnan S, Rawdin A, Wong R, Ara R & Brazier J (2019) An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy, 17(3), 295-313. View this article in WRRO
• Wu J, Xie S, He X, Chen G & Brazier JE (2019) PNS246 EXPLORING THE PERFORMANCE OF USING DISCRETE CHOICE EXPERIMENTS FOR ELICITING HEALTH STATE UTILITIES IN CHINA: EVIDENCE FROM SF-6D V2. Value in Health, 22, S327-S328.
• Xie S, He X, Wu J, Chen G & Brazier JE (2019) PNS240 A COMPARISON OF METHODS FOR ANCHORING DCE-DERIVED LATENT UTILITIES ONTO THE QALY SCALE: EVIDENCE FROM SF-6D V2. Value in Health, 22, S326-S327.
• Grundy A, Keetharuth D, Barber R, Carlton J, Connell J, Taylor Buck E, Barkham M, Ricketts T, Robotham D, Rose D , Kay J et al (2019) Public Involvement in health outcomes research: lessons learnt from the development of the Recovering Quality of Life (ReQoL) measures.. Health and Quality of Life Outcomes, 17. View this article in WRRO
• Powell PA, Carlton J, Rowen D & Brazier J (2019) Producing a preference-based quality of life measure for people with Duchenne muscular dystrophy: A mixed-methods study protocol. BMJ Open, 9. View this article in WRRO
• Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B, Cruz L, Karnon J, Lloyd A, Paisley S & Pickard AS (2019) Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report. Value in Health, 22(3), 267-275. View this article in WRRO
• Franklin M, Mukuria C, Mulhern B, Tran I, Brazier J & Watson S (2019) Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity. The Patient - Patient-Centered Outcomes Research, 1-13. View this article in WRRO
• Caro JJ, Brazier JE, Karnon J, Kolominsky-Rabas P, McGuire AJ, Nord E & Schlander M (2019) Determining value in health technology assessment: Stay the course or tack away?. PharmacoEconomics, 37(3), 293-299. View this article in WRRO
• Peasgood T, Carlton J & Brazier J (2019) A Qualitative Study of the Views of Health and Social Care Decision-makers on the Role of Wellbeing in Resource Allocation Decisions in the UK. Economies, 7(1). View this article in WRRO
• Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK , Luhmann UFO et al (2019) MACUSTAR: Entwicklung und klinische Validierung von funktionellen, strukturellen und patientenberichteten Endpunkten bei intermediärer altersabhängiger Makuladegeneration. Der Ophthalmologe, 116(12), 1186-1193.
• Brazier JE, Rowen DL, Lloyd A & Karimi M (2019) Future directions in valuing benefits for estimating QALYs: is time up for the EQ-5D?. Value in Health, 22(1), 62-68. View this article in WRRO
• Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P , Normand G et al (2019) MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration. Ophthalmologica, 241(2), 61-72.
• Keetharuth D, Bjorner JB, Barkham M, Browne J, Croudace T & Brazier J (2018) Exploring the item sets of the Recovering Quality of Life (ReQoL) measures using factor analysis. Quality of Life Research. View this article in WRRO
• Uttley L, Carlton J, Woods HB & Brazier J (2018) A review of quality of life themes in Duchenne muscular dystrophy for patients and carers.. Health and Quality of Life Outcomes, 16. View this article in WRRO
• Ballinger R, Macey J, Lloyd A, Brazier J, Ablett J, Burden S & Lal S (2018) Measurement of Utilities Associated with Parenteral Support Requirement in Patients with Short Bowel Syndrome and Intestinal Failure. Clinical Therapeutics, 40(11), 1878-1893.e1. View this article in WRRO
• Patel PJ, Steel DH, Hirneiß C, Brazier J, Aly A & Lescrauwaet B (2018) Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study. Eye (Basingstoke). View this article in WRRO
• Priedane E, Phillips GA, Brazier JE, Johnson C, Gomes-Faria R & Kumar A (2018) PSY197 - LIMITATIONS OF THE EQ5D INSTRUMENT IN THE ASSESSMENT OF QUALITY OF LIFE IN CHRONIC RARE DISEASES – A CASE STUDY FROM FCS. Value in Health, 21, S469-S470.
• Foster A, Croot L, Brazier J, Harris J & O'Cathain A (2018) The facilitators and barriers to implementing patient reported outcome measures in organisations delivering health related services: a systematic review of reviews. Journal of Patient-Reported Outcomes. View this article in WRRO
• Finch AP, Brazier JE & Mukuria C (2018) Selecting Bolt-On Dimensions for the EQ-5D: Examining Their Contribution to Health-Related Quality of Life. Value in Health. View this article in WRRO
• Whalley D, Globe G, Crawford R, Doward L, Tafesse E, Brazier J & Price D (2018) Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective. Health and Quality of Life Outcomes, 16. View this article in WRRO
• Rowen DL, Labeit A, Stevens K, Elliot J, Mulhern B, Carlton J, Basarir H & Brazier J (2018) Estimating a preference-based single index measuring the quality of life impact of self-management for diabetes. Medical Decision Making, 38(6), 699-707. View this article in WRRO
• Keetharuth D, Taylor Buck E, Acquadro C, Conway K, Connell J, Barkham M, Carlton J, Ricketts TN, Barber R & Brazier JE (2018) Integrating Qualitative and Quantitative Data in the Development of Outcome Measures: The Case of the Recovering Quality of Life (ReQoL) Measures in Mental Health Populations. International Journal of Environmental Research and Public Health, 15(7), 1342-1342. View this article in WRRO
• Devlin N, Brazier J, Pickard AS & Stolk E (2018) 3L, 5L, What the L? A NICE Conundrum. PharmacoEconomics, 36, 637-640. View this article in WRRO
• Devlin N, Brazier J, Simon Pickard A & Stolk E (2018) Correction to: 3L, 5L, What the L? A NICE Conundrum. PharmacoEconomics, 36(6), 729-729.
• Keetharuth D, Brazier J, Connell J, Bjorner J, Carlton J, Taylor Buck E, Ricketts T, McKendrick K, Browne J, Croudace T & Barkham M (2018) Recovering Quality of Life (ReQoL): a new generic self-reported outcome measure for use with people experiencing mental health difficulties. The British journal of psychiatry : the journal of mental science, 212(1), 42-49. View this article in WRRO
• Brazier J, Briggs A & Bryan S (2018) EQ-5D-5L: Smaller steps but a major step change?. Health Economics, 27(1), 4-6.
• Rowen DL, Stevens K, Labeit A, Elliott J, Mulhern B, Carlton J, Basarir H, Ratcliffe J & Brazier J (2018) Using a Discrete Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes. Value in Health, 21(1), 69-77. View this article in WRRO
• King MT, Viney R, Pickard AS, Rowen DL, Aaronson NK, Brazier JE, Cella DF, Costa DSJ, Fayers PM, Kemmler G , McTaggart-Cowan H et al (2017) Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. Phamacoeconomics. View this article in WRRO
• Ara R & Brazier J (2017) Estimating Health State Utility Values for Comorbidities. PharmacoEconomics. View this article in WRRO
• Ara RM, Peasgood T, Mukuria C, Chevrou-Severac H, Rowen D, Azzabi-Zouraq I, Paisley S, van Hout B & Brazier J (2017) Sourcing and using appropriate health state utility values in economic models in health care. PharmacoEconomics, 35(Suppl 1), 7-9. View this article in WRRO
• Ara R, Brazier J & Young T (2017) Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies. PharmacoEconomics. View this article in WRRO
• Ara RM, brazier J & azzabi-zouraq I (2017) The Use of Health State Utility Values In Decision Models. PharmacoEconomics, 35(Suppl 1), 77-88. View this article in WRRO
• Ara R, Brazier J, Peasgood T & Paisley S (2017) The Identification, Review and Synthesis of Health State Utility Values from the Literature. PharmacoEconomics, 35(Suppl 1), 43-55. View this article in WRRO
• Brazier J, Ara R, Rowen DL & Chevrou-Severac H (2017) A REVIEW OF GENERIC PREFERENCE-BASED MEASURES FOR USE IN COST-EFFECTIVENESS MODELS. PharmacoEconomics, 35(Suppl 1), 21-31. View this article in WRRO
• Rowen DL, Brazier J, Ara R & Azzabi Zouraq I (2017) The Role Of Condition-Specific Preference-Based Measures In Health Technology Assessment. PharmacoEconomics, 35(Suppl 1), 33-41. View this article in WRRO
• Tong T, Thokala P, McMillan B, Ghosh R & Brazier J (2017) Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care. International Journal of Geriatric Psychiatry, 32(12), 1392-1400. View this article in WRRO
• Brazier J, Rowen DL, Karimi M, Peasgood T, Tsuchiya A & Ratcliffe J (2017) Experience-based utility and own health state valuation for a health state classification system: why do it and how to do it. The European Journal of Health Economics. View this article in WRRO
• Brazier JE, Muston D, Konwea H, Power GS, Barzey V, Lloyd A, Sowade O, Vitti B, Gerlinger C & Roberts J (2017) Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies. Investigative Ophthalmology and Visual Science, 58(11), 4818-4825. View this article in WRRO
• Mulhern B, Labeit A, Rowen DL, Knowles E, Meadows K, Elliott J & Brazier J (2017) Developing preference-based measures for diabetes: DHP-3D and DHP-5D. Diabetic Medicine, 34(9), 1264-1275. View this article in WRRO
• Carlton J, Elliott J, Rowen D, Stevens K, Basarir H, Meadows K & Brazier J (2017) Developing a questionnaire to determine the impact of self-management in diabetes: giving people with diabetes a voice. Health and Quality of Life Outcomes, 15. View this article in WRRO
• Finch AP, Brazier JE, Mukuria C & Bjorner JB (2017) An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions: The EQ-5D Case Study. Value in Health. View this article in WRRO
• Stevens K, Brazier J & Rowen DL (2017) Estimating an exchange rate between the EQ-5D-3L and ASCOT. European Journal of Health Economics. View this article in WRRO
• Finch AP, Brazier JE & Mukuria C (2017) What is the evidence for the performance of generic preference-based measures? A systematic overview of reviews. European Journal of Health Economics, 19(4), 557-570. View this article in WRRO
• Karimi M, Brazier J & Paisley S (2017) Are preferences over health states informed?. Health and Quality of Life Outcomes, 15. View this article in WRRO
• Mulhern B, Pink J, Rowen D, Borghs S, Butt T, Hughes D, Marson A & Brazier J (2017) Comparing Generic and Condition-Specific Preference-Based Measures in Epilepsy: EQ-5D-3L and NEWQOL-6D. Value in Health, 20(4), 687-693. View this article in WRRO
• Saxon D, Ashley K, Bishop-Edwards L, Connell J, Harrison P, Ohlsen S, Hardy GE, Kellett S, Mukuria C, Mank T , Bower P et al (2017) A pragmatic randomised controlled trial assessing the non-inferiority of counselling for depression versus cognitive-behaviour therapy for patients in primary care meeting a diagnosis of moderate or severe depression (PRaCTICED): Study protocol for a randomised controlled trial.. Trials, 18(1), 93-93. View this article in WRRO
• Mukuria C, Young T, Keetharuth A, Borghs S & Brazier J (2017) Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam. Quality of Life Research, 26(3), 749-759. View this article in WRRO
• Kearns B, Rafia R, Leaviss J, Preston L, Brazier JE, Palmer S & Ara R (2017) The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Services Research, 17(1), 78-78. View this article in WRRO
• Mulhern B, Norman R, Lorgelly P, Lancsar E, Ratcliffe J, Brazier J & Viney R (2017) Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?. PharmacoEconomics, 35(4), 439-451. View this article in WRRO
• Karimi M, Brazier J & Paisley S (2016) How do individuals value health states? A qualitative investigation. Social Science & Medicine, 172, 80-88. View this article in WRRO
• Lorgelly PK, Doble B, Rowen D, Brazier J & Cancer 2015 investigators (2016) Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.. Qual Life Res. View this article in WRRO
• Peasgood T, Bhardwaj A, Biggs K, Brazier JE, Coghill D, Cooper CL, Daley D, De Silva C, Harpin V, Hodgkins P , Nadkarni A et al (2016) The impact of ADHD on the health and well-being of ADHD children and their siblings. European Child & Adolescent Psychiatry, 25(11), 1217-1231. View this article in WRRO
• Hall JP, Gurung SP, Keane PM, Poynton FE, Cardin DJ, Sorensen T, Winter G, Gunnlaugsson T, Sazanovich IV, Towrie M , Kelly JM et al (2016) DNA structure and dynamics – a combinational approach. Acta Crystallographica Section A Foundations and Advances, 72(a1), s49-s50.
• Ratcliffe J, Huynh E, Chen G, Stevens K, Swait J, Brazier J, Sawyer M, Roberts R & Flynn T (2016) Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm. Social Science & Medicine, 157, 48-59. View this article in WRRO
• Feher MD, Brazier J, Schaper N, Vega-Hernandez G, Nikolajsen A & Bøgelund M (2016) Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes. BMJ Open Diabetes Research and Care, 4(1). View this article in WRRO
• Keane PM, Baptista FR, Gurung SP, Devereux SJ, Sazanovich IV, Towrie M, Brazier JA, Cardin CJ, Kelly JM & Quinn SJ (2016) Back Cover: Long-Lived Excited-State Dynamics of i-Motif Structures Probed by Time-Resolved Infrared Spectroscopy (ChemPhysChem 9/2016). ChemPhysChem, 17(9), 1388-1388.
• King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R , Pickard AS et al (2016) QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research, 25(3), 625-636.
• Karimi M & Brazier J (2016) Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. PharmacoEconomics, 34(7), 645-649. View this article in WRRO
• Keane PM, Baptista FR, Gurung SP, Devereux SJ, Sazanovich IV, Towrie M, Brazier JA, Cardin CJ, Kelly JM & Quinn SJ (2016) Long-Lived Excited-State Dynamics of i-Motif Structures Probed by Time-Resolved Infrared Spectroscopy. ChemPhysChem, 17(9), 1281-1287.
• Rowen D, Brazier J, Mukuria C, Keetharuth A, Risa Hole A, Tsuchiya A, Whyte S & Shackley P (2016) Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Medical Decision Making, 36(2), 210-222.
• Rowen D, Brazier J, Keetharuth A, Tsuchiya A & Mukuria C (2016) Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness. Applied Health Economics and Health Policy, 14(1), 89-104. View this article in WRRO
• Croudace T, Brazier J, Gutacker N, Street A, Robotham D, Waterman S, Rose D, Satkunanathan S, Wykes T, Nasr N , Enderby P et al (2016) Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research : Sheffield, UK. 9th June 2016. Health and quality of life outcomes, 14(Suppl 1).
• Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2016) Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 25(3), 637-649.
• Tilling C, Krol M, Attema AE, Tsuchiya A, Brazier J, van Exel J & Brouwer W (2016) Exploring a new method for deriving the monetary value of a QALY. The European Journal of Health Economics, 17(7), 801-809. View this article in WRRO
• Ratcliffe J, Huynh E, Stevens K, Brazier J, Sawyer M & Flynn T (2016) Nothing about Us Without Us? A Comparison of Adolescent and Adult Health-State Values for the Child Health Utility-9D Using Profile Case Best-Worst Scaling. Health Economics (United Kingdom), 25(4), 486-496.
• Ferreira LN, Ferreira PL, Pereira LN, Brazier J & Rowen D (2015) A Portuguese Value Set for the SF-6D (vol 13, pg 624, 2010). VALUE IN HEALTH, 18(8), 1162-1162.
• Ferreira LN, Ferreira PL, Pereira LN, Rowen D & Brazier JE (2015) Exploring the Consistency of the SF-6D (vol 16, pg 1023, 2013). VALUE IN HEALTH, 18(8), 1162-1162.
• Yang Y, Brazier J & Longworth L (2015) EQ-5D in skin conditions: an assessment of validity and responsiveness. The European Journal of Health Economics, 16(9), 927-939. View this article in WRRO
• Mulhern B, O’Gorman H, Rotherham N & Brazier J (2015) Comparing the measurement equivalence of EQ-5D-5L across different modes of administration. Health and Quality of Life Outcomes, 13(1). View this article in WRRO
• Mulatero C, Lal R, Jewitt K, Tolley C, Wells J, Arbuckle R, Lloyd A, Brazier J & Devlin N (2015) Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers. Value in Health, 18(7), A469-A469.
• Peasgood T & Brazier J (2015) Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?. PharmacoEconomics, 33(11), 1101-1105. View this article in WRRO
• Hall JP, Poynton FE, Keane PM, Gurung SP, Brazier JA, Cardin DJ, Winter G, Gunnlaugsson T, Sazanovich IV, Towrie M , Cardin CJ et al (2015) Monitoring one-electron photo-oxidation of guanine in DNA crystals using ultrafast infrared spectroscopy. Nature Chemistry, 7(12), 961-967.
• Bansback N, Mulhern B, Sawatzky R, Brazier J & Whitehurst DG (2015) Valuing the SF-6D Version 2 in Canada. QUALITY OF LIFE RESEARCH, 24, 180-181.
• Young TA, Mukuria C, Rowen D, Brazier JE & Longworth L (2015) Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L. Medical Decision Making, 35(7), 912-926. View this article in WRRO
• Brazier J & Tsuchiya A (2015) Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY. Applied Health Economics and Health Policy, 13(6), 557-565. View this article in WRRO
• Mukuria C, Rowen D, Brazier JE, Young TA & Nafees B (2015) Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF. Value in Health, 18(6), 846-855.
• Hall JP, Poynton FE, Keane PM, Gurung SP, Brazier JA, Cardin DJ, Winter G, Gunnlaugsson T, Sazanovich IV, Towrie M , Cardin CJ et al (2015) Combining X-ray crystallography and ultrafast infrared spectroscopy – monitoring photo-induced guanine oxidation by [Ru(TAP)₂(dppz)]²⁺. Acta Crystallographica Section A Foundations and Advances, 71(a1), s492-s493.
• Kikuta K, Piao H, Brazier J, Taniguchi Y, Onizuka K, Nagatsugi F & Sasaki S (2015) Stabilization of the i-motif structure by the intra-strand cross-link formation.. Bioorg Med Chem Lett, 25(16), 3307-3310.
• Ratcliffe J, Chen G, Stevens K, Bradley S, Couzner L, Brazier J, Sawyer M, Roberts R, Huynh E & Flynn T (2015) Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study. Applied Health Economics and Health Policy, 13(5), 485-492. View this article in WRRO
• Mulhern B, Brazier J & Bjorner JB (2015) Developing Sf-6d-V2: Examining The Dimensionality Of The Sf-36 Using Large Multinational Datasets. Value in Health, 18(3), A27-A27.
• Rowen D, Brazier J & Van Hout B (2015) A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale. Medical Decision Making, 35(3), 328-340. View this article in WRRO
• Marques da Silva P, Haag U, Guest JF, Brazier JE & Soro M (2015) Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension. Health and Quality of Life Outcomes, 13(1), 24-24. View this article in WRRO
• Kerr C, Breheny K, Lloyd A, Brazier J, Bailey DB, Berry-Kravis E, Cohen J & Petrillo J (2015) Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome. Quality of Life Research, 24(2), 305-314. View this article in WRRO
• Chen G, Flynn T, Stevens K, Brazier J, Huynh E, Sawyer M, Roberts R & Ratcliffe J (2015) Assessing the Health-Related Quality of Life of Australian Adolescents: An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments. Value in Health, 18(4), 432-438.
• Yang Y, Rowen D, Brazier J, Tsuchiya A, Young T & Longworth L (2015) An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D. Value in Health, 18(1), 52-60. View this article in WRRO
• Rowen D, Mulhern B, Banerjee S, Tait R, Watchurst C, Smith SC, Young TA, Knapp M & Brazier JE (2015) Comparison of General Population, Patient, and Carer Utility Values for Dementia Health States. Medical Decision Making, 35(1), 68-80. View this article in WRRO
• Wu M, Brazier JE, Kearns B, Relton C, Smith C & Cooper CL (2015) Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample. European Journal of Health Economics, 16(2), 141-151. View this article in WRRO
• Hall JP, Sanchez-Weatherby J, Alberti C, Quimper CH, O’Sullivan K, Brazier JA, Winter G, Sorensen T, Kelly JM, Cardin DJ & Cardin CJ (2014) Controlled Dehydration of a Ruthenium Complex–DNA Crystal Induces Reversible DNA Kinking. Journal of the American Chemical Society, 136(50), 17505-17512.
• Longworth L, Singh J & Brazier J (2014) An Evaluation of the Performance of Eq-5d: A Review of Reviews of Psychometric Properties. Value in Health, 17(7), A570-A570.
• O'Gorman H, Mulhern B, Brazier J & Rotherham N (2014) Comparing the Equivalence of Eq-5d-5l Across Different Modes of Administration. Value in Health, 17(7), A517-A517.
• Nafees B, Cowie MR, Patel C, Deschaseaux C, Brazier J & Lloyd AJ (2014) Health State Utilities In Chronic Heart Failure In The Uk. Value in Health, 17(7), A493-A493.
• Connell J, O'Cathain A & Brazier J (2014) Measuring quality of life in mental health: Are we asking the right questions?. Social Science & Medicine, 120, 12-20. View this article in WRRO
• Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard AS & Arbuckle R (2014) The development of cancer-specific multi-attribute utility instruments from the EORTC QLQ-C30 and FACT-G. QUALITY OF LIFE RESEARCH, 23, 28-29.
• Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D & Brazier J (2014) Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D.. Br J Psychiatry, 205(3), 236-243.
• Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, Ratcliffe J & Street D (2014) Valuing SF-6D Health States Using a Discrete Choice Experiment.. Med Decis Making, 34(6), 773-786.
• Ara R, Kearns B, vanHout BA & Brazier JE (2014) Predicting preference-based utility values using partial proportional odds models. BMC Research Notes, 7(1). View this article in WRRO
• Kharroubi SA, Brazier JE & Yang Y (2014) Modeling a preference-based index for two condition-specific measures (asthma and overactive bladder) using a nonparametric Bayesian method.. Value Health, 17(4), 406-415.
• Mulhern B, Rowen D, Snape D, Jacoby A, Marson T, Hughes D, Baker G & Brazier J (2014) Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population.. Epilepsy Behav, 36, 12-17.
• Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Lloyd MJ, Paisley S, O’Cathain A, Barkham M , Knapp M et al (2014) A systematic review, psychometric analysis and qualitative assessment of Generic Preference-Based Measures of Health in Mental Health Populations and the estimation of mapping functions from widely used specific measures. Health Technology Assessment, 18(34).
• Wu M, Brazier J, Relton C, Cooper C, Smith C & Blackburn J (2014) Examining the incremental impact of long-standing health conditions on subjective well-being alongside the EQ-5D. Health and Quality of Life Outcomes, 12(1). View this article in WRRO
• Rentz AM, Kowalski JW, Walt JG, Hays RD, Brazier JE, Yu R, Lee P, Bressler N & Revicki DA (2014) Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.. JAMA Ophthalmol, 132(3), 310-318.
• Whitehurst DGT, Norman R, Viney R & Brazier JE (2014) Comparison of Contemporaneous EQ-5D and SF-6D Responses Using Scoring Algorithms Derived from Similar Valuation Exercises. Value in Health.
• Kharroubi SA, Brazier JE & McGhee S (2014) A Comparison of Hong Kong and United Kingdom SF-6D Health States Valuations Using a Nonparametric Bayesian Method. Value in Health.
• Yang Y, Brazier J & Tsuchiya A (2014) Effect of adding a sleep dimension to the EQ-5D descriptive system: A "bolt-on" experiment. Medical Decision Making, 34(1), 42-53. View this article in WRRO
• Matza LS, Currie B, Palsgrove A, Davies E, Chung K, Braun A, Van Brunt K, Brazier JE & Body J-J (2014) Health state utilities for skeletal-related events secondary to bone metastases. European Journal of Health Economics, 15(1), 7-18. View this article in WRRO
• Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P , Devianee Keetharuth A et al (2014) Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.. Health Technol Assess, 18(9), 1-224. View this article in WRRO
• Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L , Rowen D et al (2014) Preparatory study for the revaluation of the EQ-5D tariff: methodology report.. Health Technol Assess, 18(12), vii-191. View this article in WRRO
• Poku E, Brazier J, Carlton J & Ferreira A (2013) Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.. BMC Ophthalmol, 13, 74. View this article in WRRO
• Yang Y, Longworth L & Brazier J (2013) An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment. Quality of Life Research, 1-16. View this article in WRRO
• Sprange K, Mountain GA, Brazier J, Cook SP, Craig C, Hind D, Walters SJ, Windle G, Woods R, Keetharuth AD , Chater T et al (2013) Lifestyle Matters for maintenance of health and wellbeing in people aged 65 years and over: study protocol for a randomised controlled trial.. Trials, 14, 302. View this article in WRRO
• Ferreira LN, Ferreira PL, Pereira LN, Rowen D & Brazier JE (2013) Exploring the consistency of the SF-6D.. Value Health, 16(6), 1023-1031.
• Kharroubi SA, Brazier JE & McGhee S (2013) Modeling SF-6D hong kong standard gamble health state preference data using a nonparametric bayesian method. Value in Health, 16(6), 1032-1045.
• Al-Janabi H, Coast J, Peters TJ, Brazier J, Bryan S, Flynn TN, Clemens S & Moody A (2013) An investigation of the construct validity of the ICECAP-A capability measure. Quality of Life Research, 22(7), 1831-1840. View this article in WRRO
• Craig BM, Pickard AS, Stolk E & Brazier JE (2013) US valuation of the SF-6D. Medical Decision Making, 33(6), 793-803.
• Papaioannou D, Brazier J & Paisley S (2013) Systematic searching and selection of health state utility values from the literature. Value in Health, 16(4), 686-695.
• Alava MH, Brazier J, Rowen D & Tsuchiya A (2013) Common scale valuations across different preference-based measures: estimation using rank data.. Med Decis Making, 33(6), 839-852.
• Bansback N, Brazier J, Tsuchiya A & Anis A (2013) Erratum to "Using a discrete choice experiment to estimate health state utility values" [J. Health Econ. 31 (1) (2012) 306-318]. Journal of Health Economics, 32(2), 486-486.
• Papaioannou D, Brazier J & Parry G (2013) How to measure quality of life for cost-effectiveness analyses of personality disorders: a systematic review.. J Pers Disord, 27(3), 383-401.
• Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, Watchurst C, Chua K-C, Loftus V, Young T , Lamping D et al (2013) Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation.. Health Technol Assess, 17(5), v-140.
• Mukuria C, Brazier J, Barkham M, Connell J, Hardy G, Hutten R, Saxon D, Dent-Brown K & Parry G (2013) Cost-effectiveness of an improving access to psychological therapies service.. Br J Psychiatry, 202(3), 220-227.
• Alonso J, Bartlett SJ, Rose M, Aaronson NK, Chaplin JE, Efficace F, Leplège A, LU A, Tulsky DS, Raat H , Ravens-Sieberer U et al (2013) The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health and Quality of Life Outcomes, 11(1), 210-210. View this article in WRRO
• Lloyd A, Kerr C, Breheny K, Brazier J, Ortiz A & Borg E (2013) Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoL™). Quality of Life Research, 1-10.
• Viney R, Norman R, Cronin P, Brazier J, King MT, Ratcliffe J & Street D (2013) An Australian Discrete Choice Experiment To Value EQ-5D Health States. Health Economics (United Kingdom).
• Lu G, Brazier JE & Ades AE (2013) Mapping from disease-specific to generic health-related quality-of-life scales: A common factor model. Value in Health, 16(1), 177-184.
• Mulhern B, Longworth L, Brazier J, Rowen D, Bansback N, Devlin N & Tsuchiya A (2013) Binary choice health state valuation and mode of administration: head-to-head comparison of online and CAPI.. Value Health, 16(1), 104-113. View this article in WRRO
• Mavranezouli I, Brazier JE, Rowen D & Barkham M (2013) Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D.. Med Decis Making, 33(3), 381-395.
• Rowen D, Young T, Brazier J & Gaugris S (2012) Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.. Value Health, 15(8), 1059-1068.
• Connell J, Brazier J, O'Cathain A, Lloyd-Jones M & Paisley S (2012) Quality of life of people with mental health problems: a synthesis of qualitative research.. Health Qual Life Outcomes, 10, 138. View this article in WRRO
• Brazier JA, Shah A & Brown GD (2012) I-Motif formation in gene promoters: unusually stable formation in sequences complementary to known G-quadruplexes. Chemical Communications, 48(87), 10739-10739.
• Norman R, Brazier JE, Viney R, Burgess L, Cronin P, King MT, Ratcliffe J & Street D (2012) Revaluing the SF-6D using ordinal methods for eliciting preferences. QUALITY OF LIFE RESEARCH, 21, 6-6.
• Brazier J, Mulhern B, Alonso J, Connell J, Papaioannou D & Vilagut G (2012) Are generic preference-based measures valid in mental health? A mixed methods enquiry. QUALITY OF LIFE RESEARCH, 21, 1-1.
• Kazis LE, Selim AJ, Rogers W, Qian SX & Brazier J (2012) Monitoring outcomes for the Medicare Advantage program: methods and application of the VR-12 for evaluation of plans.. The Journal of ambulatory care management, 35(4), 263-276.
• Browne C, Brazier J, Carlton J, Alavi Y & Jofre-Bonet M (2012) Estimating quality-adjusted life years from patient-reported visual functioning. Eye (Basingstoke), 26(10), 1295-1301.
• Kazis LE, Selim AJ, Rogers W, Qian SX & Brazier J (2012) Monitoring outcomes for the Medicare Advantage program: methods and application of the VR-12 for evaluation of plans.. J Ambul Care Manage, 35(4), 263-276.
• Mulhern B, Brazier JE, Rowen D, Young TA, Smith SC & Banerjee S (2012) Response to Comments on Mulhern et al., "Improving the Measurement of QALYs in Dementia: Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis".. Value Health, 15(5), 787-788.
• Brazier JE, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y, Barkham M & Ibbotson R (2012) Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).. Health Technol Assess, 16(32), 1-114.
• Brazier JS (2012) Clostridium difficile: The anaerobe that made the grade. Anaerobe, 18(2), 197-199.
• Netten A, Burge P, Malley J, Potoglou D, Towers A-M, Brazier J, Flynn T, Forder J & Wall B (2012) Outcomes of social care for adults: developing a preference-weighted measure. HEALTH TECHNOLOGY ASSESSMENT, 16(16), 1-+.
• Malley JN, Towers A-M, Netten AP, Brazier JE, Forder JE & Flynn T (2012) An assessment of the construct validity of the ASCOT measure of social care-related quality of life with older people. HEALTH AND QUALITY OF LIFE OUTCOMES, 10. View this article in WRRO
• Bansback N, Tsuchiya A, Brazier J & Anis A (2012) Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies. PLOS ONE, 7(2). View this article in WRRO
• Mukuria C & Brazier J (2012) Valuing the EQ-5D and the SF-6D health states using subjective well-being: A secondary analysis of patient data. Social Science and Medicine.
• Ratcliffe J, Stevens K, Flynn T, Brazier J & Sawyer MG (2012) Whose values in health? An empirical comparison of the application of adolescent and adult values for the CHU-9D and AQOL-6D in the Australian adolescent general population. Value in Health, 15(5), 730-736.
• Mulhern B, Smith SC, Rowen D, Brazier JE, Knapp M, Lamping DL, Loftus V, Young TA, Howard RJ & Banerjee S (2012) Improving the measurement of QALYs in dementia: Developing patient- and carer-reported health state classification systems using Rasch analysis. Value in Health, 15(2), 323-333. View this article in WRRO
• Rowen D, Mulhern B, Banerjee S, Van Hout B, Young TA, Knapp M, Smith SC, Lamping DL & Brazier JE (2012) Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-proxy. Value in Health, 15(2), 346-356.
• Ratcliffe J, Flynn T, Terlich F, Stevens K, Brazier J & Sawyer M (2012) Developing adolescent-specific health state values for economic evaluation: An application of profile case best-worst scaling to the child health utility 9D. PharmacoEconomics, 30(8), 713-727.
• Kerr C, Lloyd A, Rowen D, Maslen T & Brazier J (2012) Androgen deprivation therapy for prostate cancer prevention: What impact do related adverse events have on quality of life?. Health Outcomes Research in Medicine, 3(3).
• Mulhern B, Rowen D, Jacoby A, Marson T, Snape D, Hughes D, Latimer N, Baker GA & Brazier JE (2012) The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy and Behavior, 24(1), 36-43.
• Tosh J, Brazier J, Evans P & Longworth L (2012) A review of generic preference-based measures of health-related quality of life in visual disorders.. Value Health, 15(1), 118-127.
• Bansback N, Brazier J, Tsuchiya A & Anis A (2012) Using a discrete choice experiment to estimate health state utility values.. J Health Econ, 31(1), 306-318.
• Tilling C, Krol M, Tsuchiya A, Brazier J, Exel JV & Brouwer W (2012) Does the EQ-5D reflect lost earnings?. Pharmacoeconomics, 30(1), 47-61.
• Ara R & Brazier J (2012) Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.. Med Care, 50(5), 452-459. View this article in WRRO
• McTaggart-Cowan HM, O'Cathain A, Tsuchiya A & Brazier JE (2012) Using mixed methods research to explore the effect of an adaptation exercise on general population valuations of health states.. Qual Life Res, 21(3), 465-473.
• Rowen D, Brazier J, Tsuchiya A, Young T & Ibbotson R (2012) It's all in the name, or is it? The impact of labeling on health state values.. Med Decis Making, 32(1), 31-40.
• Rowen D, Brazier J, Tsuchiya A & Alava MH (2012) Valuing states from multiple measures on the same visual analogue sale: A feasibility study. Health Economics, 21(6), 715-729.
• Burton M, Walters SJ, Saleh M & Brazier JE (2012) An evaluation of patient-reported outcome measures in lower limb reconstruction surgery.. Qual Life Res, 21(10), 1731-1743.
• Brazier J, Rowen D, Yang Y & Tsuchiya A (2012) Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale.. Eur J Health Econ, 13(5), 575-587.
• Lloyd A, Hodgkins P, Sasane R, Akehurst R, Sonuga-Barke EJS, Fitzgerald P, Nixon A, Erder H & Brazier J (2011) Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 4(4), 247-257.
• Salhiyyah K, Elsobky S, Raja S, Attia R, Brazier J & Cooper GJ (2011) A clinical and economic evaluation of fast-track recovery after cardiac surgery.. Heart Surg Forum, 14(6), E330-E334.
• Mutebi A, Brazier JE & Walters SJ (2011) A comparison of the discriminative and evaluative properties of the SF-36 and the SF-6D index. QUAL LIFE RES, 20(9), 1477-1486.
• Selim AJ, Rogers W, Qian SX, Brazier J & Kazis LE (2011) A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey. QUAL LIFE RES, 20(8), 1337-1347.
• Papaioannou D, Brazier J & Parry G (2011) How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review.. Value Health, 14(6), 907-920.
• Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT & Velikova G (2011) Deriving a preference-based measure for cancer using the EORTC QLQ-C30.. Value Health, 14(5), 721-731. View this article in WRRO
• Ara R & Brazier J (2011) Estimating health state utility values for comorbid health conditions using SF-6D data.. Value Health, 14(5), 740-745. View this article in WRRO
• Ara R & Brazier JE (2011) Using health state utility values from the general population to approximate baselines in decision analytic models when condition-specific data are not available.. Value Health, 14(4), 539-545. View this article in WRRO
• Matza LS, Van Brunt K, Chung K, Brazier J, Braun AH, Currie B & Body J (2011) Health state utilities for skeletal-related events associated with bone metastases.. J Clin Oncol, 29(15_suppl), e16620.
• Matza LS, Van Brunt K, Chung K, Brazier J, Braun AH, Currie B & Body J (2011) Health state utilities for skeletal-related events associated with bone metastases. JOURNAL OF CLINICAL ONCOLOGY, 29(15).
• Potoglou D, Burge P, Flynn T, Netten A, Malley J, Forder J & Brazier JE (2011) Best-worst scaling vs. discrete choice experiments: An empirical comparison using social care data. SOC SCI MED, 72(10), 1717-1727. View this article in WRRO
• McTaggart-Cowan H, Tsuchiya A, O'Cathain A & Brazier J (2011) Understanding the effect of disease adaptation information on general population values for hypothetical health states.. Soc Sci Med, 72(11), 1904-1912.
• Yang Y, Brazier JE, Tsuchiya A & Young TA (2011) Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire.. Med Decis Making, 31(2), 281-291.
• McGhee SM, Brazier J, Lam CLK, Wong LC, Chau J, Cheung A & Ho A (2011) Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(6 SUPPL 6), 17-21.
• Schwenkglenks M, Brazier JE, Szucs TD & Fox KAA (2011) Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes. VALUE IN HEALTH, 14(1), 24-33.
• Ratcliffe J, Stevens K, Flynn T, Brazier J & Sawyer M (2011) An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Quality of Life Research, 1-9.
• McTaggart-Cowan HM, O'Cathain A, Tsuchiya A & Brazier JE (2011) Using mixed methods research to explore the effect of an adaptation exercise on general population valuations of health states. Quality of Life Research, 1-9.
• Cruz LN, Camey SA, Hoffmann JF, Rowen D, Brazier JE, Fleck MP & Polanczyk CA (2011) Estimating the SF-6D value set for a population-based sample of Brazilians. Value in Health, 14(5 SUPPL.).
• Kowalski JW, Rentz AM, Walt JG, Lloyd A, Lee J, Young TA, Chen W-H, Bressler NM, Lee P, Brazier JE , Hays RD et al (2011) Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation. Quality of Life Research, 1-12.
• Brazier J, Rowen D, Tsuchiya A, Yang Y & Young TA (2011) The impact of adding an extra dimension to a preference-based measure.. Soc Sci Med, 73(2), 245-253.
• Mavranezouli I, Brazier JE, Young TA & Barkham M (2011) Using rasch analysis to form plausible health states amenable to valuation: The development of CORE-6D from a measure of common mental health problems (CORE-OM). Quality of Life Research, 20(3), 321-333. View this article in WRRO
• Young TA, Yang Y, Brazier JE & Tsuchiya A (2011) The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D.. Med Decis Making, 31(1), 195-210.
• Ratcliffe J, Couzner L, Flynn T, Sawyer M, Stevens K, Brazier J & Burgess L (2011) Valuing child health utility 9D health states with a young adolescent sample: A feasibility study to compare best-worst scaling discrete-choice experiment, standard gamble and time trade-off methods. Applied Health Economics and Health Policy, 9(1), 15-27.
• Ferreira LN, Ferreira PL, Rowen D & Brazier JE (2011) Do Portuguese and UK health state values differ across valuation methods?. Qual Life Res, 20(4), 609-619.
• Versteegh MM, Rowen D, Brazier JE & Stolk EA (2010) Mapping onto Eq-5 D for patients in poor health.. Health Qual Life Outcomes, 8, 141. View this article in WRRO
• Lloyd A, Kerr C, Rowen D, Maslen T & Brazier J (2010) PIH32 TREATMENTS TO PREVENT PROSTATE CANCER AND THEIR IMPACT ON HEALTH RELATED QUALITY OF LIFE. Value in Health, 13(7), A380-A381.
• Szende A, Schaefer C & Brazier J (2010) PSY66 WEB VERSUS FACE-TO-FACE (FTF) ADMINISTRATION OF A HEALTH UTILITY SURVEY IN THE GENERAL PUBLIC: RESULTS FROM A TIME TRADE-OFF (TTO) SURVEY ON IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP). Value in Health, 13(7), a472.
• Brazier J (2010) Developing preference-based measures from existing quality of life measures: why, how and should we?. QUALITY OF LIFE RESEARCH, 19, 2-2.
• Clauser SB, Brazier J, Feeny D, Revicki DA & Kind P (2010) Development and Comparisons of Alternative Preference-Based Measures of Health. QUALITY OF LIFE RESEARCH, 19, 2-2.
• Peasgood T, Ward SE & Brazier J (2010) Health-state utility values in breast cancer.. Expert Rev Pharmacoecon Outcomes Res, 10(5), 553-566.
• Palfreyman SJ, Tod AM, Brazier JE & Michaels JA (2010) A systematic review of health-related quality of life instruments used for people with venous ulcers: an assessment of their suitability and psychometric properties.. J Clin Nurs, 19(19-20), 2673-2703.
• Szende A, Brazier J, Schaefer C, Deuson R, Isitt JJ & Vyas P (2010) Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura. CURR MED RES OPIN, 26(8), 1893-1903.
• Cunillera O, Tresserras R, Rajmil L, Vilagut G, Brugulat P, Herdman M, Mompart A, Medina A, Pardo Y, Alonso J , Brazier J et al (2010) Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey. QUAL LIFE RES, 19(6), 853-864.
• Kharroubi SA, O'Hagan A & Brazier JE (2010) A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method. STAT MED, 29(15), 1622-1634.
• Ferreira LN, Ferreira PL, Pereira LN, Brazier J & Rowen D (2010) A Portuguese Value Set for the SF-6D. VALUE HEALTH, 13(5), 624-630.
• McTaggart-Cowan HM, Brazier JE & Tsuchiya A (2010) Clustering Rasch results: a novel method for developing rheumatoid arthritis states for use in valuation studies.. Value Health, 13(6), 787-795.
• Thorpe L, Thomas K, Fitter M, Brazier J, MacPherson H, Campbell M, Nicholl J, Morgan A & Roman M (2010) Acupuncture in the management of persistent low back pain: findings to date of a pragmatic, randomised controlled trial. Focus on Alternative and Complementary Therapies, 7(1), 113-113.
• Thomas K, Fitter M, Brazier J, MacPherson H, Campbell M, Nicholl J, Thorpe L, Morgan A & Roman M (2010) Making research relevant - design of a pragmatic RCT of clinical and cost effectiveness of acupuncture in a primary care setting. Focus on Alternative and Complementary Therapies, 6(1), 93-94.
• Young TA, Rowen D, Norquist J & Brazier JE (2010) Developing preference-based health measures: using Rasch analysis to generate health state values.. Qual Life Res, 19(6), 907-917.
• Brazier JE, Yang Y, Tsuchiya A & Rowen DL (2010) A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures.. Eur J Health Econ, 11(2), 215-225.
• Ara R & Brazier JE (2010) Populating an economic model with health state utility values: moving toward better practice.. Value Health, 13(5), 509-518.
• Palfreyman SJ, Shackley P & Brazier JE (2010) Assessing current health-related quality of life questionnaires administered to patients with venous ulcers: can they be used in economic evaluations?. J CLIN NURS, 19(5-6), 892-897.
• Brazier J & Tsuchiya A (2010) PREFERENCE-BASED CONDITION-SPECIFIC MEASURES OF HEALTH: WHAT HAPPENS TO CROSS PROGRAMME COMPARABILITY?. HEALTH ECON, 19(2), 125-129.
• Hind D, Scott EJ, Copeland R, Breckon JD, Crank H, Walters SJ, Brazier JE, Nicholl J, Cooper C & Goyder E (2010) A randomised controlled trial and cost-effectiveness evaluation of "booster" interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods.. BMC Public Health, 10, 3. View this article in WRRO
• Tilling C, Krol M, Tsuchiya A, Brazier J & Brouwer W (2010) In or out? Income losses in health state valuations: a review.. Value Health, 13(2), 298-305.
• Brazier JE, Fukuhara S, Roberts J, Kharroubi S, Yamamoto Y, Ikeda S, Doherty J & Kurokawa K (2009) Estimating a preference-based index from the Japanese SF-36.. J Clin Epidemiol, 62(12), 1323-1331. View this article in WRRO
• Ratcliffe J, Brazier J, Tsuchiya A, Symonds T & Brown M (2009) USING DCE AND RANKING DATA TO ESTIMATE CARDINAL VALUES FOR HEALTH STATES FOR DERIVING A PREFERENCE-BASED SINGLE INDEX FROM THE SEXUAL QUALITY OF LIFE QUESTIONNAIRE. HEALTH ECON, 18(11), 1261-1276.
• Pyne JM, Fortney JC, Tripathi S, Feeny D, Ubel P & Brazier J (2009) How Bad Is Depression? Preference Score Estimates from Depressed Patients and the General Population. HEALTH SERV RES, 44(4), 1406-1423.
• Peasgood T, Herrmann K, Kanis JA & Brazier JE (2009) An updated systematic review of Health State Utility Values for osteoporosis related conditions.. Osteoporos Int, 20(6), 853-868.
• Stein K, Dyer M, Milne R, Round A, Ratcliffe J & Brazier J (2009) The precision of health state valuation by members of the general public using the standard gamble. QUAL LIFE RES, 18(4), 509-518.
• Czoski-Murray C, Carlton J, Brazier J, Young T, Papo NL & Kang HK (2009) Valuing condition-specific health states using simulation contact lenses.. Value Health, 12(5), 793-799.
• Mann R, Brazier J & Tsuchiya A (2009) A comparison of patient and general population weightings of EQ-5D dimensions.. Health Econ, 18(3), 363-372.
• Young T, Yang Y, Brazier JE, Tsuchiya A & Coyne K (2009) The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis.. Qual Life Res, 18(2), 253-265.
• Rowen D, Brazier J & Roberts J (2009) Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?. Health Qual Life Outcomes, 7, 27.
• Brazier JE, Dixon S & Ratcliffe J (2009) The role of patient preferences in cost-effectiveness analysis: a conflict of values?. Pharmacoeconomics, 27(9), 705-712.
• Ara R & Brazier J (2009) Predicting the Short Form-6D preference-based index using the eight mean Short Form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available. Value in Health, 2(12), 346-353.
• Ara R & Brazier J (2008) Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available).. Value Health, 11(7), 1131-1143.
• Brazier J (2008) Measuring and valuing mental health for use in economic evaluation.. J Health Serv Res Policy, 13 Suppl 3, 70-75.
• McKenna SP, Ratcliffe J, Meads DM & Brazier JE (2008) Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses. HEALTH QUAL LIFE OUT, 6. View this article in WRRO
• Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, Symmons D & Anis A (2008) Health state utility values: A description of their development and application for rheumatic diseases. ARTHRIT RHEUM-ARTHR, 59(7), 1018-1026.
• Bevan G & Brazier J (2008) EQUITY AND EFFICIENCY: CLARIFYING CONFUSION FOR ENGLISH ACUTE HOSPITALS. Financial Accountability and Management, 1(2), 173-189.
• (2008) Erratum. Nucleosides Nucleotides & Nucleic Acids, 27(4), 431-431.
• McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, FitzGerald JM, Anis AH & Lynd LD (2008) The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. QUAL LIFE RES, 17(3), 453-462.
• Lam CLK, Brazier J & McGhee SM (2008) Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. VALUE HEALTH, 11(2), 295-303.
• Noronha Ferreira L, Lopes Ferreira P, Nobre Pereira L & Brazier J (2008) An application of the SF-6D to create health values in Portuguese working age adults. Journal of Medical Economics, 11(2), 215-233.
• Brazier J (2008) Valuing health States for use in cost-effectiveness analysis.. Pharmacoeconomics, 26(9), 769-779.
• Brazier J, Czoski-Murray C, Roberts J, Brown M, Symonds T & Kelleher C (2008) Estimation of a preference-based index from a condition-specific measure: the King's Health Questionnaire.. Med Decis Making, 28(1), 113-126.
• Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes.. Health technology assessment (Winchester, England), 11(52).
• Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes. HEALTH TECHNOL ASSES, 11(52), 1-+. View this article in WRRO
• Reuber M, Burness C, Howlett S, Brazier J & Grünewald R (2007) Tailored psychotherapy for patients with functional neurological symptoms: a pilot study.. J Psychosom Res, 63(6), 625-632.
• Bansback N, Davis S & Brazier J (2007) Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration.. Eye (Lond), 21(12), 1455-1463.
• Stevens K, McCabe C, Brazier J & Roberts J (2007) Multi-attribute utility function or statistical inference models: a comparison of health state valuation models using the HUI2 health state classification system.. J Health Econ, 26(5), 992-1002.
• Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T & Brazier J (2007) Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. ARTHRIT RHEUM-ARTHR, 57(6), 963-971.
• Brazier J & Tsuchiya A (2007) The Role of Condition Specific Measures in Economic Evaluation: It's a Trade-Off.
• Palfreyman SJ, Tod AM, King B, Tomlinson D, Brazier JE & Michaels JA (2007) Impact of intravenous drug use on quality of life for patients with venous ulcers.. J Adv Nurs, 58(5), 458-467.
• Kharroubi SA, Brazier JE, Roberts J & O'Hagan A (2007) Modelling SF-6D health state preference data using a nonparametric Bayesian method. J HEALTH ECON, 26(3), 597-612. View this article in WRRO
• Ratcliffe J, Brazier J, Palfreyman S & Michaels J (2007) A comparison of patient and population values for health states in varicose veins patients.. Health Econ, 16(4), 395-405.
• Bansback N, Czoski-Murray C, Carlton J, Lewis G, Hughes L, Espallargues M, Brand C & Brazier J (2007) Determinants of health related quality of life and health state utility in patients with age related macular degeneration: the association of contrast sensitivity and visual acuity.. Qual Life Res, 16(3), 533-543.
• Kharroubi S, Brazier JE & O'Hagan A (2007) Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method. SOC SCI MED, 64(6), 1242-1252.
• Stevens K, McCabe C & Brazier J (2007) Response to Shmueli. Health Economics, 16(7), 759-761.
• Palfreyman S, Michaels J & Brazier J (2007) Development of a tool to examine the effect of venous ulcers on patients’ quality of life. Nursing Standard, 21(45), 57-69.
• Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M & Brazier J (2007) Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence.. J Health Serv Res Policy, 12(1), 56-58.
• Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes.. Health technology assessment (Winchester, England), 11(52).
• Tappenden P, Brazier J, Ratcliffe J & Chilcott J (2007) A stated preference binary choice experiment to explore NICE decision making.. Pharmacoeconomics, 25(8), 685-693.
• McCloskey EV, Beneton M, Charlesworth D, Kayan K, deTakats D, Dey A, Orgee J, Ashford R, Forster M, Cliffe J , Kersh L et al (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study.. J Bone Miner Res, 22(1), 135-141.
• Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M & Brazier J (2007) Not so... [2]. Journal of Health Services Research and Policy, 12(3), 190-191.
• Stein K, Dyer M, Crabb T, Milne R, Round A, Ratcliffe J & Brazier J (2006) A pilot Internet "Value of Health" Panel: recruitment, participation and compliance. HEALTH QUAL LIFE OUT, 4. View this article in WRRO
• Ratcliffe J, Thomas KJ, MacPherson H & Brazier J (2006) A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis.. BMJ, 333(7569), 626. View this article in WRRO
• Thomas KJ, MacPherson H, Thorpe L, Brazier J, Fitter M, Campbell MJ, Roman M, Walters SJ & Nicholl J (2006) Randomised controlled trial of a short course of traditional acupuncture compared with usual care for persistent non-specific low back pain.. BMJ, 333(7569), 623.
• Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G & Sutcliffe P (2006) Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.. Health Technol Assess, 10(33), iii-168. View this article in WRRO
• Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent-Brown K & Paisley S (2006) Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation.. Health Technol Assess, 10(35), iii-117.
• McCabe C, Stevens K, Roberts J & Brazier J (2006) Erratum to ‘Health state values for the health utilities index mark 2 descriptive system: results from a UK valuation survey’Health Economics 2005;14(3): 231–244. Health Economics, 15(7), 761-761.
• Brazier J, Dolan P, Karampela K & Towers I (2006) Does the whole equal the sum of the parts? Patient-assigned utility scores for IBS-related health states and profiles.. Health Econ, 15(6), 543-551.
• McCabe C, Brazier J, Gilks P, Tsuchiya A, Roberts J, O'Hagan A & Stevens K (2006) Using rank data to estimate health state utility models.. J Health Econ, 25(3), 418-431. View this article in WRRO
• Michales JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J & Rigby K (2006) Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). HEALTH TECHNOL ASSES, 10(13), III-+.
• Stein K, Ratcliffe J, Round A, Milne R & Brazier JE (2006) Impact of discussion on preferences elicited in a group setting. HEALTH QUAL LIFE OUT, 4. View this article in WRRO
• Tsuchiya A, Brazier J & Roberts J (2006) Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.. J Health Econ, 25(2), 334-346.
• Ratcliffe J, Brazier JE, Campbell WB, Palfreyman S, MacIntyre JB & Michaels JA (2006) Cost-effectiveness analysis of surgery versus conservative treatment for uncomplicated varicose veins in a randomized clinical trial.. Br J Surg, 93(2), 182-186.
• Michaels JA, Brazier JE, Campbell WB, MacIntyre JB, Palfreyman SJ & Ratcliffe J (2006) Randomized clinical trial comparing surgery with conservative treatment for uncomplicated varicose veins.. Br J Surg, 93(2), 175-181.
• Claxton K, Sculpher M, Culyer A, McCabe C, Briggs A, Akehurst R, Buxton M & Brazier J (2006) Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion.. Health Econ, 15(1), 1-4.
• Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA, Brand CS & Brazier JE (2005) The impact of age-related macular degeneration on health status utility values.. Invest Ophthalmol Vis Sci, 46(11), 4016-4023.
• Elliott SL, Brazier J, Cosstick R & Connolly BA (2005) Mechanism of the Escherichia coli DNA T:G-mismatch endonuclease (Vsr protein) probed with thiophosphate-containing oligodeoxynucleotides.. J Mol Biol, 353(3), 692-703.
• Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health technology assessment (Winchester, England), 9(32).
• Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health Technol Assess, 9(32), iii-109.
• Walters SJ & Brazier JE (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.. Qual Life Res, 14(6), 1523-1532.
• Stevens KJ, Brazier JE, McKenna SP, Doward LC & Cork MJ (2005) The development of a preference-based measure of health in children with atopic dermatitis.. Br J Dermatol, 153(2), 372-377.
• Towers I, Spencer A & Brazier J (2005) Healthy year equivalents versus quality-adjusted life years: the debate continues.. Expert Rev Pharmacoecon Outcomes Res, 5(3), 245-254.
• Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, Brazier JE, Fortin PR & Anis AH (2005) Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?. QUAL LIFE RES, 14(5), 1333-1344.
• McCabe CJ, Stevens KJ & Brazier JE (2005) Utility scores for the Health Utilities Index Mark 2: an empirical assessment of alternative mapping functions.. Med Care, 43(6), 627-635.
• Kharroubi SA, O'Hagan A & Brazier JE (2005) Estimating utilities from individual health preference data: a nonparametric Bayesian method. J ROY STAT SOC C-APP, 54, 879-895. View this article in WRRO
• Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, Brazier J & O'Hagan T (2005) Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. HEALTH ECON, 14(4), 339-347. View this article in WRRO
• Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM & Anis AH (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. SOC SCI MED, 60(7), 1571-1582.
• McCabe C, Stevens K, Roberts J & Brazier J (2005) Health state values for the HUI 2 descriptive system: results from a UK survey.. Health Econ, 14(3), 231-244.
• Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2005) Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women. J OPER RES SOC, 56(2), 214-221.
• Stein K, Fry A, Round A, Milne R & Brazier J (2005) What value health? A review of health state values used in early technology assessments for NICE. Applied Health Economics and Health Policy, 4(4), 219-228.
• Hibbert CL, Coates EJ, Brazier JE & Morris J (2005) A cost survey of 70 adult critical care units - Results from a volunteer sample in England, Scotland and Northern Ireland in 2003. Care of the Critically Ill, 21(1), 8-17.
• Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health technology assessment (Winchester, England), 9(32).
• Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M & Tsuchyia A (2005) Should patients have a greater role in valuing health states?. Appl Health Econ Health Policy, 4(4), 201-208.
• Brazier JE, Roberts J, Platts M & Zoellner YF (2005) Estimating a preference-based index for a menopause specific health quality of life questionnaire.. Health Qual Life Outcomes, 3, 13. View this article in WRRO
• Munro JF, Nicholl JP, Brazier JE, Davey R & Cochrane T (2004) Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial.. J Epidemiol Community Health, 58(12), 1004-1010. View this article in WRRO
• Littlejohns P, Leng G, Culyer T & Drummond M (2004) NICE clinical guidelines: Maybe health economists should participate in guideline development. BMJ, 329(7465), 571.1-571.1.
• Hatoum HT, Brazier JE & Akhras KS (2004) Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. VALUE HEALTH, 7(5), 602-609.
• Brazier J, Roberts J, Tsuchiya A & Busschbach J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups.. Health Econ, 13(9), 873-884. View this article in WRRO
• Brazier JE & Roberts J (2004) The estimation of a preference-based measure of health from the SF-12.. Med Care, 42(9), 851-859.
• Brazier JE, Kolotkin RL, Crosby RD & Williams GR (2004) Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D.. Value Health, 7(4), 490-498.
• Littlejohns P, Leng G, Culyer T, Drummond M, Pilling S, Dutchak J, McInnes E, Macbeth F, Pearson M, Thomas J , Turnbull N et al (2004) NICE clinical guidelines [2] (multiple letters). British Medical Journal, 329(7465), 571-572. View this article in WRRO
• Wailoo A, Roberts J, Brazier J & McCabe C (2004) Efficiency, equity, and NICE clinical guidelines. British Medical Journal, 328(7439), 536-537. View this article in WRRO
• Simren M, Brazier J, Coremans G, Dapoigny M, Muller-Lissner SA, Pace F, Smout AJPM, Stockbrugger RW, Vatn MH & Whorwell PJ (2004) Quality of life and illness costs in irritable bowel syndrome. DIGESTION, 69(4), 254-261.
• Krabbe PFM, Adang EMM, Stalmeier PFM, Schackman BR, Brazier J & Weinstein MC (2003) Letter to the Editor. Medical Decision Making, 23(6), 542-543.
• O'Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P & Brazier J (2003) A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. HEALTH ECON, 12(11), 975-981. View this article in WRRO
• Brazier J, Green C, McCabe C & Stevens K (2003) Use of visual analog scales in economic evaluation.. Expert Rev Pharmacoecon Outcomes Res, 3(3), 293-302.
• Paterson C, Ewings P, Brazier JE & Britten N (2003) Treating dyspepsia with acupuncture and homeopathy: reflections on a pilot study by researchers, practitioners and participants. COMPLEMENT THER MED, 11(2), 78-84.
• Walters SJ & Brazier JE (2003) Sample sizes for the SF-6D preference based measure of health from the SF-36: A comparison of two methods. Health Services and Outcomes Research Methodology, 4(1), 35-47.
• Walters SJ & Brazier JE (2003) What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.. Health Qual Life Outcomes, 1, 4. View this article in WRRO
• Brazier JE, Green C, Kanis JA & Committee Of Scientific Advisors International Osteoporosis Foundation (2002) A systematic review of health state utility values for osteoporosis-related conditions.. Osteoporos Int, 13(10), 768-776.
• Macpherson H, Thomas K, Brazier J, Fitter M, Thorpe L, Campbell M, Nicholl J, Roman M & Morgan A (2002) Longer-Term Clinical and Economic Benefits of Offering Acupuncture to Patients with Chronic Low Back Pain Assessed as Suitable for Primary Care Management – 3 Month Clinical Outcomes from a Controlled Trial of 241 Patients. Acupuncture in Medicine, 20(2-3), 121-137.
• Robinson J, Brazier J & Beard J (2002) Patient-determined quality of life measure in critical limb ischaemia. BRIT J SURG, 89(4), 526-526.
• Brazier J, Roberts J & Deverill M (2002) The estimation of a preference-based measure of health from the SF-36.. J Health Econ, 21(2), 271-292. View this article in WRRO
• Kanis JA, Brazier JE, Stevenson M, Calvert NW & Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis.. Health technology assessment (Winchester, England), 6(29), 1-146.
• Kanis JA, Brazier JE, Stevenson M, Calvert NW & Jones ML (2002) Treatment of established osteoporosis: A systematic review and cost-utility analysis. Health Technology Assessment, 6(29). View this article in WRRO
• Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J & Weinstein MC (2002) Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. MED DECIS MAKING, 22(1), 27-38.
• Brazier J & Fitzpatrick R (2002) Measures of health-related quality of life in an imperfect world: a comment on Dowie.. Health Econ, 11(1), 17-19. View this article in WRRO
• Kanis JA, Brazier JE, Stevenson M, Calvert NW & Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis.. Health Technol Assess, 6(29), 1-146.
• Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, Platts M & Walters SJ (2002) Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.. Pharmacoeconomics, 20(7), 455-462.
• Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J & Weinstein MC (2001) PID6: HIV/AIDS HEALTH STATE UTILITIES USING COMMUNITY AND PATIENT PREFERENCE WEIGHTS: WHEN DOES IT MATTER?. Value in Health, 4(2), 130-130.
• Crawford B & Brazier JE (2001) PAM15: EVALUATING DIRECT AND INDIRECT MEASURES OF UTILITY: STABILITY OF THE SF-6D IN A RHEUMATOID ARTHRITIS POPULATION. Value in Health, 4(2), 71-71.
• Crawford B, Brazier JE, Strand V & Doyle J (2001) PAM14: TREATMENT WITH LEFLUNOMIDE IMPROVES THE UTILITY OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: AN APPLICATION OF THE SF-6D. Value in Health, 4(2), 71-71.
• Brazier JE, Green C & Kanis J (2001) MS4: A SYSTEMATIC REVIEW OF HEALTH STATE VALUES FOR OSTEOPOROSIS RELATED CONDITIONS. Value in Health, 4(2), 64-64.
• Hatoum H, Brazier J, Akhras K, Boyer J & Tooley J (2001) CV4: COMPARISON BETWEEN INVESTIGATOR AND PATIENT'S GLOBAL HEALTH ASSESSMENTS USING CALCULATED HUI-III AND SF-36 UTILITY VALUES. Value in Health, 4(6), 408.
• Walters SJ, Munro JF & Brazier JE (2001) Using the SF-36 with older adults: a cross-sectional community-based survey.. Age Ageing, 30(4), 337-343. View this article in WRRO
• Michaels JA, Campbell WB, Rigby KA, Chan P, Beard J, Wood R, Lonsdale RJ, Sheriff S, Palfreyman S, Thompson J , Allington K et al (2001) A New Pragmatic Classification System for Varicose Veins. Phlebology: The Journal of Venous Disease, 16(1), 29-33.
• Brazier JE & Johnson AG (2001) Economics of surgery. Lancet, 358(9287), 1077-1081.
• Morgan A, Shackley P, Pickin M & Brazier J (2000) Quantifying patient preferences for out-of-hours primary care.. J Health Serv Res Policy, 5(4), 214-218.
• Cotton L, Brazier J, Hall DM, Lindsay G, Marsh P, Polnay L & Williams TS (2000) School nursing: costs and potential benefits.. J Adv Nurs, 31(5), 1063-1071.
• Michaels J, Palfreyman S, Shackley P, Slack R & Brazier J (2000) Modelling the effects of the reorganization of vascular services. British Journal of Surgery, 87(4), 515-515.
• Green C, Brazier J & Deverill M (2000) Valuing health-related quality of life. A review of health state valuation techniques.. Pharmacoeconomics, 17(2), 151-165.
• Akehurst R, Anderson P, Brazier JE, Brennan A, Briggs , Buxton M & et al (2000) Decision analytic modelling in the economics evaluation of health care technologies: a consensus statement. PharmacoEconomics(4), 161-163.
• Brazier JE (2000) Decision Analytic modelling in the Economic Evaluation of Health Technologies: A consensus statement. PharmacoEconomics, 5(17), 443-444.
• Michaels J, Brazier J, Palfreyman S, Shackley P & Slack R (2000) Cost and outcome implications of the organisation of vascular services. Health Technology Assessment, 4(11).
• Brazier JE, Harper R, Munro J, Walters SJ & Snaith ML (1999) Generic and condition-specific outcome measures for people with osteoarthritis of the knee.. Rheumatology (Oxford), 38(9), 870-877.
• Brazier J, Deverill M & Green C (1999) A review of the use of health status measures in economic evaluation.. J Health Serv Res Policy, 4(3), 174-184.
• Dixon S, Deverill M, Gannon M, Brazier J & Haggard M (1999) Improving the validity of economic evaluations alongside controlled trials.. J Health Serv Res Policy, 4(3), 161-163.
• Thomas KJ, Fitter M, Brazier J, MacPherson H, Campbell M, Nicholl JP & Roman M (1999) Longer-term clinical and economic benefits of offering acupuncture to patients with chronic low back pain assessed as suitable for primary care management.. Complement Ther Med, 7(2), 91-100.
• Brazier J & Deverill M (1999) A checklist for judging preference-based measures of health related quality of life: learning from psychometrics.. Health Econ, 8(1), 41-51.
• Brazier J, Deverill M, Green C, Harper R & Booth A (1999) A review of the use of health status measures in economic evaluation. Health Technology Assessment, 3(9).
• Wight JP, Edwards L, Brazier J, Walters S, Payne JN & Brown CB (1998) The SF36 as an outcome measure of services for end stage renal failure.. Qual Health Care, 7(4), 209-221. View this article in WRRO
• Keller SD, Ware JE, Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Kaasa S , Leplege A et al (1998) Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1179-1188.
• Gandek B, Ware JE, Aaronson NK, Alonso J, Apolone G, Bjorner J, Brazier J, Bullinger M, Fukuhara S, Kaasa S , Leplege A et al (1998) Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1149-1158.
• Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A , Prieto L et al (1998) The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1159-1165.
• Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L , Sullivan M et al (1998) The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1167-1170.
• Raczek AE, Ware JE, Bjorner JB, Gandek B, Haley SM, Aaronson NK, Apolone G, Bech P, Brazier JE, Bullinger M & Sullivan M (1998) Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1203-1214.
• Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L & Sullivan M (1998) Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1171-1178.
• Brazier J, Usherwood T, Harper R & Thomas K (1998) Deriving a preference-based single index from the UK SF-36 Health Survey.. J Clin Epidemiol, 51(11), 1115-1128.
• Deverill M, Brazier J, Green C & Booth A (1998) The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art.. Pharmacoeconomics, 13(4), 411-420.
• Keller SD, Ware JE, Gandek B, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Fukuhara S , Kaasa S et al (1998) Testing the equivalence of translations of widely used response choice labels: Results from the IQOLA Project. Journal of Clinical Epidemiology, 51(11), 933-944.
• Munro J, Brazier J, Davey R & Nicholl J (1997) Physical activity for the over-65s: could it be a cost-effective exercise for the NHS?. J Public Health Med, 19(4), 397-402.
• Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM & Howard P (1997) Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.. Thorax, 52(10), 879-887. View this article in WRRO
• McCabe CJ, Thomas KJ, Brazier JE & Coleman P (1996) Measuring the mental health status of a population: a comparison of the GHQ-12 and the SF-36 (MHI-5).. Br J Psychiatry, 169(4), 516-521.
• Brazier J, Nicholl J & Snooks H (1996) The cost and effectiveness of the London Helicopter Emergency Medical Service.. J Health Serv Res Policy, 1(4), 232-237.
• Brazier JE, Walters SJ, Nicholl JP & Kohler B (1996) Using the SF-36 and Euroqol on an elderly population.. Qual Life Res, 5(2), 195-204.
• Snooks HA, Nicholl JP, Brazier JE & Lees-Mlanga S (1996) The costs and benefits of helicopter emergency ambulance services in England and Wales.. J Public Health Med, 18(1), 67-77.
• McCloskey E, Luchetti M, Bernard J, deTakats D, Brazier J, Nicholl J & Kanis J (1996) Bone loss at the hip in elderly women is prevented by oral clodronate — A pilot study. Osteoporosis International, 6(S1), 271-271.
• Alexander W, Bradley C, Brazier J, Campbell K, Chadwick J, Clements D, Hall G, Mackinnon M, McLeod C, Miles K , Roberts S et al (1996) The report of the Clinical Care Group. Diabetic Medicine, 13(SUPPL. 4).
• Nicholl J, Snooks H & Brazier J (1995) Authors' reply. BMJ, 311(7013), 1166-1166.
• Nicholl JP, Brazier JE & Snooks HA (1995) Effects of London helicopter emergency medical service on survival after trauma.. BMJ, 311(6999), 217-222.
• Brazier J & Dixon S (1995) The use of condition specific outcome measures in economic appraisal.. Health Econ, 4(4), 255-264.
• Brazier J (1995) The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation.. Pharmacoeconomics, 7(5), 403-415.
• Bowling A & Brazier J (1995) Introduction. Social Science & Medicine, 41(10), 1337-1338.
• NICHOLL J, SNOOKS H & BRAZIER J (1995) EFFECTS OF HELICOPTER SERVICE ON SURVIVAL AFTER TRAUMA - REPLY. BRIT MED J, 311(7013), 1166-1166.
• WARE JE, KELLER SD, GANDEK B, BRAZIER JE & SULLIVAN M (1995) EVALUATING TRANSLATIONS OF HEALTH-STATUS QUESTIONNAIRES - METHODS FROM THE IQOLA PROJECT. INT J TECHNOL ASSESS, 11(3), 525-551.
• Lowy A, Brazier J, Fall M, Thomas K, Jones N & Williams BT (1994) Quality of minor surgery by general practitioners in 1990 and 1991.. Br J Gen Pract, 44(385), 364-365.
• Nicholl JP, Beeby NR & Brazier JE (1994) A comparison of the costs and performance of an emergency helicopter and land ambulances in a rural area.. Injury, 25(3), 145-153.
• Nicholl JP, Coleman P & Brazier JE (1994) Health and healthcare costs and benefits of exercise.. Pharmacoeconomics, 5(2), 109-122.
• Nicholl JP, Ross B, Milner PC, Brazier JE, Westlake L, Kohler B, Frost E, Williams BT & Johnson AG (1994) Cost effectiveness of adjuvant bile salt treatment in extracorporeal shock wave lithotripsy for the treatment of gall bladder stones. Gut, 35(9), 1294-1300.
• WARE JE, GANDEK B, AARONSON NK, ACQUADRO C, ALONSO J, APOLONE G, BECH P, BRAZIER J, BULLINGER M, FUKUHARA S , KAASA S et al (1994) THE SF-36 HEALTH SURVEY - DEVELOPMENT AND USE IN MENTAL-HEALTH RESEARCH AND THE IQOLA PROJECT. INT J MENT HEALTH, 23(2), 49-73.
• Nicholl J, Brazier J & Beeby N (1994) Author's reply. Injury, 25(10), 690.
• Brazier J (1993) The SF-36 health survey questionnaire--a tool for economists.. Health Econ, 2(3), 213-215.
• Lowy A, Brazier J, Fall M, Thomas K, Jones N & Williams BT (1993) Minor surgery by general practitioners under the 1990 contract: effects on hospital workload.. BMJ, 307(6901), 413-417.
• Murmu LR (1993) Laparoscopic versus mini-incision cholecystectomy.. Lancet, 341(8836), 47-48.
• Brazier J (1992) Competition and planning in the NHS: The danger of unplanned markets Calum Paton. Chapman and Hall, London, 1992. No. of pages: 157. ISBN 0-412-47060-8. Health Economics, 1(3), 208-209.
• Gompertz P, Harwood R, Ebrahim S & Dickinson E (1992) Validating the SF-36.. BMJ, 305(6854), 645-646.
• Brazier J, Harper R, Jones N, Thomas K, Westlake L & Usherwood T (1992) Validating the SF-36: Authors' reply. BMJ, 305(6854), 646-646.
• Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T & Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care.. BMJ, 305(6846), 160-164.
• Triger DR, Johnson AG, Brazier JE, Johnston GW, Spencer EFA, McKee R, Anderson JR & Carter DC (1992) A prospective trial of endoscopic sclerotherapy v oesophageal transection and gastric devascularisation in the long term management of bleeding oesophageal varices. Gut, 33(11), 1553-1558.
• Nicholl JP, Brazier JE, Milner PC, Westlake C, Kohler B, Williams BT, Ross B, Frost E & Johnson AG (1992) Randomised controlled trial of cost-effectiveness of lithotripsy and open cholecystectomy as treatments for gallbladder stones. The Lancet, 340(8823), 801-807.
• O'Cathain A, Brazier JE, Milner PC & Fall M (1992) Cost effectiveness of minor surgery in general practice: a prospective comparison with hospital practice.. Br J Gen Pract, 42(354), 13-17.
• George S & Brazier J (1991) Information needs in a provider market: a case-study of ENT.. J Public Health Med, 13(2), 108-114.
• Page H & Brazier J (1991) The funding debate revisited: who's for the mixed economy?. Health Serv Manage, 87(2), 84-86.
• BRAZIER JE & NORMAND CEM (1991) AN ECONOMIC-REVIEW OF THE NHS WHITE PAPER. SCOT J POLIT ECON, 38(1), 96-105.
• Bromwich P, Walker A, Dalton M, Lilford RJ, Page H, Brazier J, Edwards RG, Brinsden P, Elder K, Lewis P , Macnamee M et al (1989) BENEFITS OF IN-VITRO FERTILISATION. The Lancet, 334(8675), 1327-1329.
• Milner PC, Brazier JE, Nicholl JP, Ross B & Johnson AG (1989) EVALUATING GALLBLADDER LITHOTRIPSY. The Lancet, 334(8653), 51.
• Brazier J (1987) Accounting for cross boundary flows.. Br Med J (Clin Res Ed), 295(6603), 898-900.
• Bevan G & Brazier J (1987) Financial incentives of subregional RAWP.. Br Med J (Clin Res Ed), 295(6602), 836-838.
• Bevan G & Brazier J (1985) EQUITY AND EFFICIENCY: CLARIFYING CONFUSION FOR ENGLISH ACUTE HOSPITALS. Financial Accountability and Management, 1(2), 173-189.
• Bevan G & Brazier J (1985) Moving resources. Subregional RAWP--Hobson's choice?. Health and social service journal, 95(4963), 1064-1065.
• Brazier JE & Bevan G (1985) Equity and efficiency: clarifying the confusion for English acute hospitals.. Financial Accountability and Management, 2(1), 173-189.
• Carlton J, Powell P, Rowen D, Broadley M, Pouwer F, Speight J, Heller S, Gall M-A, Rosilio M, Child C , Comins J et al () Producing a preference-based quality of life measure to quantify the impact of hypoglycaemia on people living with diabetes: a mixed-methods research protocol. Diabetic Medicine.
• Saßmannshausen M, Behning C, Isselmann B, Schmid M, Finger RP, Holz FG, Schmitz-Valckenberg S, Pfau M, Agostini H, Altay L , Atia R et al () Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report. Scientific Reports, 12(1).
• Terheyden JH, Pondorfer SG, Behning C, Berger M, Carlton J, Rowen D, Bouchet C, Poor S, Luhmann UFO, Leal S , Holz FG et al () Disease-specific assessment of Vision Impairment in Low Luminance (VILL) in age-related macular degeneration – a MACUSTAR study report. British Journal of Ophthalmology.
• Bansback N, Trenaman L, Mulhern BJ, Norman R, Metcalfe R, Sawatzky R, Brazier J, Rowen D & Whitehurst DGT () Estimation of a Canadian preference-based scoring algorithm for the Veterans RAND 12-item Health Survey (VR-12): a population survey using a discrete choice experiment. CMAJ open. View this article in WRRO
• Pennington B, Alshreef A, Flight L, Metry A, Poku E, Hykin P, Sivaprasad S, Prevost AT, Vasconcelos JC, Murphy C , Kelly J et al () Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study. PharmacoEconomics.
• Peasgood T, Mukuria C, Carlton J, Connell J & Brazier J () Criteria for item selection for a preference-based measure for use in economic evaluation. Quality of Life Research.
• Powell P, Rowen D, Rivero-Arias O, Tsuchiya A & Brazier J () Valuing child and adolescent health: A qualitative study on different perspectives and priorities taken by the adult general public. Health and Quality of Life Outcomes.
• Powell P, Carlton J, Rowen D, Brazier J, Facey K, Bayley K, Chandler F, Godfrey J & Crossley E () Measuring What Matters – Little Evidence Supporting the Content Validity of EQ-5D in People with Duchenne Muscular Dystrophy and Their Caregivers. Medical Decision Making. View this article in WRRO
• Keetharuth AD, Bjorner JB, Barkham M, Browne J, Croudace T & Brazier J () An item response theory analysis of an item pool for the recovering quality of life (ReQoL) measure. Quality of Life Research.
• Whitehurst DGT, Brazier JE, Viney R & Mulhern BJ () The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?. PharmacoEconomics.
• Hykin P, Prevost AT, Sivaprasad S, Vasconcelos JC, Murphy C, Kelly J, Ramu J, Alshreef A, Flight L, Pennington R , Hounsome B et al () Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT. Health Technology Assessment.
• Matza LS, Stewart KD, Lloyd A, Rowen D & Brazier J () Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations. Value in Health.
• Rowen D, Powell P, Mukuria C, Carlton J, Norman R & Brazier J () Deriving a Preference-based Measure for People with Duchenne Muscular Dystrophy from the DMD-QoL. Value in Health.
• Powell PA, Carlton J, Rowen D, Chandler F, Guglieri M & Brazier JE () Development of a New Quality of Life Measure for Duchenne Muscular Dystrophy Using Mixed Methods. Neurology, 10.1212/WNL.0000000000011896-10.1212/WNL.000000000.
• Peasgood T, Mukuria C, Carlton J, Connell J, Devlin N, Jones K, Lovett R, Naidoo B, Rand S, Rejon-Parrilla JC , Rowen D et al () What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality adjusted life years? Application to the development of the EQ-HWB?. European Journal of Health Economics.
• Barkham M, Saxon D, Hardy GE, Bradburn M, Galloway D, Wickramasekera N, Keetharuth AD, Bower P, King M, Elliott R , Gabriel L et al () Clinical and cost-effectiveness of person-centred experiential therapy vs. cognitive behavioural therapy for moderate and severe depression delivered in the English Improving Access to Psychological Therapies national programme: A pragmatic randomised non- inferiority trial [PRaCTICED]. The Lancet Psychiatry.
• McDool E, Mukuria C & Brazier J () Correction to: A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population. PharmacoEconomics.

Chapters

• Brazier J & Ratcliffe J (2017) Measurement and Valuation of Health for Economic Evaluation, International Encyclopedia of Public Health (pp. 586-593). Elsevier
• Ara R & Brazier J (2014) Cost-Effectiveness Modeling Using Health State Utility Values, Encyclopedia of Health Economics (pp. 130-138). Elsevier
• Rowen D & Brazier J (2014) Multiattribute Utility Instruments: Condition-Specific Versions, Encyclopedia of Health Economics (pp. 358-365). Elsevier
• Brazier J, Roberts J & Rowen D (2012) Methods for developing preference-based measures of health In Jones A (Ed.), The Elgar Companion to Health Economics, Second Edition (pp. 395-405).
• Rowen D & Brazier J (2011) Health Utility Measurement (pp. 787-813). Oxford University Press
• Brazier J, Papaioannou D, Cantrell A, Paisley S & Herrmann K (2010) Identifying and reviewing health state utility values for populating decision models In Shemilt I, Mugford M, Vale L, Donaldson C & Marsh K (Ed.), Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice (pp. 93-105). Wiley-Blackwell
• Brazier JE (2009) SF-6D In Kattan MW & Cowen ME (Ed.), Encyclopaedia of Medical Decision Making California: Sage Publications.
• Brazier JE & Ratcliffe J (2008) The measurement and Valuation of Health for Economic Evaluation. In Heggenhougen HK & Quah S (Ed.), International Encyclopaedia of Public Health. (pp. 252-261). San Diego: Academic Press.
• Brazier JE & Roberts J (2007) Methods for developing preference-based measures of Health. In Jones A (Ed.), The Elgar Companion to Health Economics (pp. 371-381). Cheltenham UK: Edward Elgar Publishing Ltd.
• Jones M, Nardi B & Mynatt ED (2005) Introduction (pp. 147-148). Association for Computing Machinery (ACM)
• Brazier J, Nicholl J & Snooks H (2004) The cost and effectiveness of the London Helicopter Emergency Medical Service, Studying the Organisation and Delivery of Health Services (pp. 176-187).
• Brazier JE, Rice N & Roberts J (2002) Modelling health state valuation data In Murray C, Saloman J, Mathers C & Lopez A (Ed.), Summary Measures of Population Health 2002: Concepts, Ethics, Measurement and Applications (pp. 529-548). World Health Organisation
• Brazier JE & Morgan A (2002) Economic evaluation of complementary therapies, Clinical Research in complementary therapies London: Churchill Livingstone.
• Brazier JE, Deverill M & Green C (2001) The use of health related quality of life questionnaires in economic evaluation. In Stevens A, Abrams K, Brazier J, Fitzpatrick R & Lilford R (Ed.), Methods in Hdealth Technology Assessment London: Sage Books.
• Brazier JE, Green G, Ormandy D & Gilbertson J (2000) Tolerant Building: The impact of energy efficiency measures on living conditions and health status In Rudge J & Nical F (Ed.), Cutting the cost of cold: Affordable warmth for healthier homes (pp. 87-106). London: Taylor & Francis.
• Brazier JE & Deverill M (1998) The use of health related quality of life questionnaires in economic evaluation. In Black N, Fitzpatrick R & Reeves B (Ed.), Methods for Health Services Research: a state of the art guide. London: BMJ Books.
• Brazier JE (1998) The SF-36 Health Survey and its use in Pharmacoeconomics economic evaluation., Quality of Life Assessment Auckland: Adis International.
• Brazier JE & Green C (1996) Economic Evaluation in Brief In Earlam RJ (Ed.), The Royal Hospital Trauma Hospital - A Trauma Care System London.
• Brazier JE, Williams BT & Nicholl J (1996) Health Care Needs Assessment: Accident and Emergency Departments. In Stevens A & Raftery J (Ed.), Health Care Needs Assessment Frome: Radlcliffe Medical Press.
• Brazier JE & Cairns J (1996) An economic perspective on health outcome measurement. In Hutchinson & et al (Ed.), Outcome Measurement in Primary Care Amsterdam: Harwood academic publishers.
• Brazier JE & Jeavons R (1991) The economics of diabetic care In Bradley C, Christine M & West R (Ed.), The technology of diabetic care London: Harwood.
• Brazier JE, Hutton J & Jeavons R (1990) Evaluating the reform of the NHS In Culyer AJ, Maynard A & Posnett J (Ed.), Competition in Health Care: reforming the NHS London: MacMillan Press.
• Brazier JE, Jeavons R & Akehurst R (1989) The White Paper and the NHS: How much competition will there actually be?, Health Care UK Newbury: Policy Journals.
• Brazier JE (1988) District health authorities as trading organisations., Health Care UK Newbury: Policy Journals.

Conference proceedings papers

• Kharroubi S, El Harakeh M, Dawoud D, Rowen D & Brazier JE (2022) PCR175 Valuation of SF-6D Health States: Is It Feasible and Acceptable in a Lebanese Population. Value in Health, Vol. 25(7) (pp S574-S574)
• Schneider P, Brazier JE, Devlin N & van Hout B (2022) PCR28 The OPUF Tool: A New Type of Online Survey for Creating Value Sets for the EQ-5D-5L on the Societal-, Group-, and Individual Person Level. Value in Health, Vol. 25(7) (pp S546-S546)
• Schneider P, Brazier J, Devlin N & Hout BV (2022) 85:oral The EQ-5D-5L OPUF survey: quantifying health priorities on the individual person level using compositional preference elicitation techniques. Abstracts (pp a32.1-a3a32)
• Kharroubi S, El Harakeh M, Dawoud D, Rowen D & Brazier JE (2022) VALUATION OF SF-6D HEALTH STATES: IS IT FEASIBLE AND ACCEPTABLE IN A LEBANESE POPULATION. VALUE IN HEALTH, Vol. 25(7) (pp S574-S574)
• Schneider P, Brazier JE, Devlin N & van Hout B (2022) THE OPUF TOOL: A NEW TYPE OF ONLINE SURVEY FOR CREATING VALUE SETS FOR THE EQ-5D-5L ON THE SOCIETAL-, GROUP-, AND INDIVIDUAL PERSON LEVEL. VALUE IN HEALTH, Vol. 25(7) (pp S546-S546)
• Broderick L, Lauher M, White MK, Kosinski M, Mulhern B, Brazier JE & Bjorner JB (2022) PARTICIPANT REINTERPRETATION OF HEALTH STATES: A THINK-ALOUD STUDY OF DECISION-MAKING STRATEGIES IN DISCRETE CHOICE EXPERIMENTS WITH THE SF-6DV2. VALUE IN HEALTH, Vol. 25(7) (pp S551-S551)
• Holt R, Taylor S, Barretto N, Hirst A, Oliver L, Brandolini G & Brazier JE (2022) BRIDGING AND VALIDATION OF A THYROID EYE DISEASE (TED) SPECIFIC QUALITY OF LIFE (QOL) QUESTIONNAIRE TO UTILITY VALUES ASSESSED BY A TIME TRADE-OFF (TTO) ANALYSIS. VALUE IN HEALTH, Vol. 25(7) (pp S531-S531)
• Schneider P, Van Hout B, Heisen M, Brazier J & Devlin N (2022) A NEW ONLINE TOOL FOR VALUING HEALTH STATES: ELICITING PERSONAL UTILITY FUNCTIONS FOR THE EQ-5D-5L. VALUE IN HEALTH, Vol. 25(1) (pp S13-S13)
• Terheyden JH, Pondorfer SG, Behning C, Berger M, Rowen D, Carlton J, Holz FG, Butt T, Brazier JE & Finger RP (2021) Psychometric properties of the Vision Impairment in Low Luminance (VILL) questionnaire in age-related macular degeneration in the MACUSTAR study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 62(8)
• Hartl K, Durno N, Schmid R, Heisen M, Ethgen O, Szilvasy Z, Friedel E, Wong O, Charman T, San Jose Caceres A , Muehlbacher A et al (2021) Preference Study in Childhood Autism Spectrum Disorder (ASD) using the Childhood Autism Rating Scale (CARS2): A Feasibility Assessment. QUALITY OF LIFE RESEARCH, Vol. 30(SUPPL 1) (pp S113-S114)
• Broderick L, Bjorner J, Lauher M, Kosinski M, White MK, Mulhern B & Brazier JE (2021) DEVELOPMENT OF THE SF-6DV2 HEALTH UTILITY SURVEY: CONTENT VALIDITY AND PATIENT PREFERENCE. VALUE IN HEALTH, Vol. 24 (pp S193-S193)
• Xie S, Wu J, He X, Chen G & Brazier JE (2020) PNS191 TEST-RETEST RELIABILITY OF COMPOSITE TTO AND DCE WITH DURATION IN THE VALUATION OF SF-6DV2 HEALTH STATES. Value in Health, Vol. 23 (pp S319-S319)
• Wu J, Xie S, He X, Chen G & Brazier JE (2020) PP3 VALUATION OF SF-6DV2 HEALTH STATES USING TIME TRADE-OFF AND DISCRETE CHOICE EXPERIMENT WITH DURATION APPROACHES IN CHINA. Value in Health, Vol. 23 (pp S325-S325)
• Xie S, Wu J, He X, Chen G & Brazier JE (2020) TEST-RETEST RELIABILITY OF COMPOSITE TTO AND DCE WITH DURATION IN THE VALUATION OF SF-6DV2 HEALTH STATES. VALUE IN HEALTH, Vol. 23 (pp S319-S319)
• Bansback N, Mulhern B, Norman R, Trenaman L, Metcalfe R, Sawatzky R, Brazier J, Rowen D & Whitehurst DGT (2020) DEVELOPMENT OF A PREFERENCE BASED SINGLE INDEX FOR THE VR-12 IN CANADA. MEDICAL DECISION MAKING, Vol. 40(1) (pp E53-E54)
• Scarisbrick J, Schmidt F, Turini MM, D'agostino P, Thornton S, Evans J, Ader J, van Hest N & Brazier JE (2020) HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH MYCOSIS FUNGOIDES-TYPE CUTANEOUS T-CELL LYMPHOMA PATIENTS: DETERMINATION OF UTILITY VALUES FROM A UK-BASED CLINICIAN QUESTIONNAIRE. VALUE IN HEALTH, Vol. 23 (pp S715-S715)
• Schneider P, Van Hout B & Brazier J (2020) FAIR INTERPERSONAL UTILITY COMPARISON IN THE CONTEXT OF HEALTH VALUATION: DESCRIPTION AND FIRST EMPIRICAL EVALUATION OF A NEW MULTI-STEP PREFERENCE AGGREGATION PROCEDURE. MEDICAL DECISION MAKING, Vol. 40(5) (pp E407-E408)
• Brazier J (2020) Extending the QALY (E-QALY): developing a new generic preference-based measure for use with patients, carers and those needing care-an overview. QUALITY OF LIFE RESEARCH, Vol. 29(SUPPL 1) (pp S3-S3)
• Shah K, Bennett B, Lenny A, Longworth L, Brazier JE, Oppe M, Pickard AS & Shaw JW (2020) ADAPTING PREFERENCE-BASED UTILITY MEASURES TO CAPTURE THE IMPACT OF CANCER TREATMENT-RELATED SYMPTOMS. VALUE IN HEALTH, Vol. 23 (pp S430-S430)
• Flight L, Alshreef A, Hykin PG, Sivaprasad S, Pennington B, Kelly J, Murphy CL & Brazier JE (2019) Intravitreal therapy with Ranibizumab vs Aflibercept vs Bevacizumab for macular oedema due to central retinal vein occlusion : a within trial cost-utility analysis. Value in Health, Vol. 22(Suppl 3) (pp S664-S664). Copenhagen, Denmark, 2 November 2019 - 6 November 2019. View this article in WRRO
• Keetharuth A, Brazier JE, Rowen D & Bjorner J (2019) PMH29 ESTIMATING A PREFERENCE-BASE INDEX FROM THE RECOVERING QUALITY OF LIFE MEASURE FOR ECONOMIC EVALUATION IN THE AREA OF MENTAL HEALTH: VALUATION OF REQOL-UI. Value in Health, Vol. 22 (pp S685-S686)
• Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernández M (2019) PSS25 Mapping from visual acuity to utility in patients with macular oedema due to central retinal vein occlusion using data from the LEAVO trial. Value in Health, Vol. 22(Suppl. 3) (pp S891-S891). Copenhagen, Denmark, 2 November 2019 - 6 November 2019. View this article in WRRO
• Pennington B, Alshreef A, Flight L, Hykin P, Sivaprasad S, Brazier JE & Hernandez M (2019) MAPPING FROM VISUAL ACUITY TO UTILITY IN PATIENTS WITH MACULAR OEDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION USING DATA FROM THE LEAVO TRIAL. VALUE IN HEALTH, Vol. 22 (pp S891-S891)
• Acaster S, Mukuria C, Rowen D, Brazier J, Wainwright C, Quon B, Duckers J, Quittner AL, Lou Y, Sosnay P & McGarry L (2019) DEVELOPMENT OF THE CYSTIC FIBROSIS QUESTIONNAIRE-REVISED PREFERENCE BASED SCORING ALGORITHM. PEDIATRIC PULMONOLOGY, Vol. 54 (pp S443-S443)
• Pickard AS, Monteiro A, Kuharic M, Mukuria C, Peasgood T & Brazier J (2019) Extending the QALY project in the United States: face and content validity of items for a new preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S165-S165)
• Keetharuth A, Bjorner JB, Rowen D & Brazier J (2019) Using item response theory to construct a health classification system and select health states for valuation for the Preference-Based Index from the Recovering Quality of Life (ReQoL) outcome measure. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S68-S68)
• Blome C, Carlton J, Heesen C, Janssen MF, Lloyd A, Otten M, Sommer R & Brazier J (2019) How to capture fluctuating health impairments in people with multiple sclerosis: development of an intensive longitudinal assessment of the EQ-5D-5L. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S164-S164)
• Norman R, Mercieca-Bebber R, Rowen D, Brazier J, Cella D, Pickard AS, Street DJ, Viney R, Revicki D & King M (2019) UK utility weights for the cancer-specific EORTC QLU-C10D: Why, how and when to use?. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S11-S12)
• Connell J, Carlton J, Peasgood T, Mukuria C, Brazier J, Augustovski F, Belizan M, Engel L, Greiner W, Hanna L , Ludwig K et al (2018) Extending the QALY: developing and testing the proposed items for a new generic measure - results from qualitative review and face validity with patients, social care users and carers. QUALITY OF LIFE RESEARCH, Vol. 27 (pp S189-S189)
• Keetharuth A, Barkham M & Brazier J (2018) Interpreting changes in scores: the case of the Recovering Quality of Life (ReQoL). QUALITY OF LIFE RESEARCH, Vol. 27 (pp S161-S161)
• Mukuria C, Connell J, Carlton J, Peasgood T, Brazier J, Scope A, Clowes M & Jones K (2018) Developing Content for a New Generic Qaly Measure: Results from a Qualitative Literature Review (E-Qaly Project). Value in Health, Vol. 21 (pp S110-S110)
• Connell J, Carlton J, Grundy A, Taylor Buck E, Keetharuth AD, Ricketts T, Barkham M, Robotham D, Rose D & Brazier J (2018) The importance of content and face validity in instrument development: lessons learnt from service users when developing the Recovering Quality of Life measure (ReQoL). Quality of Life Research, Vol. 27(7) (pp 1893-1902) View this article in WRRO
• Petersen KD, Chen G, Mpundu-Kaambwa C, Stevens K, Brazier J & Ratcliffe J (2018) Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15. The Patient - Patient-Centered Outcomes Research, Vol. 11(1) (pp 29-37)
• King MT, Norman R, Mercieca-Bebber R, Rowen D, Bonnet P, Cella D, Pickard AS, Brazier JE, Viney R & Revicki DA (2017) Development of United Kingdom value set for EORTC QLU-C10D: multi-attribute utility classification for the EORTC-QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 26(1) (pp 50-50)
• Velikova G, Valderas JM, Potter C, Batchelder L, A’Court C, Baker M, Bostock J, Coulter A, Fitzpatrick R, Forder J , Fox D et al (2017) Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Oxford 2017: Advances in Patient Reported Outcomes Research. Health and Quality of Life Outcomes, Vol. 15(S1) View this article in WRRO
• Elliott J, Carlton J, Rowen D & Brazier J (2017) Changing HbA(1c) units: a hindarance, not a help to patients. DIABETOLOGIA, Vol. 60 (pp S342-S342)
• Lescrauwaet B, Brazier J, Aly A, Hirneiß C & Patel P (2016) Use of Novel Health-Related Quality of Life Measures to Assess The Effect of Metamorphopsia Symptoms In Patients with Vitreomacular Traction, With or Without Macular Hole: The Memo Study. Value in Health, Vol. 19(7) (pp A571-A571)
• Willson J, Mukuria CW, Labeit A, Gunsoy N, Starkie Camejo H, Alfonso-Cristancho R & Brazier J (2016) Development of a Mapping Algorithm Between the SGRQ and EQ-5D-5L Utility Values in a Severe Asthma Population. Value in Health, Vol. 19(7) (pp A385-A385)
• Ballinger RS, Macey J, Lloyd AJ & Brazier JE (2016) Utilities Associated with The Number of Days on Parenteral Support in The Treatment of Short Bowel Syndrome. Value in Health, Vol. 19(7) (pp A513-A513)
• Bjorner JB, Rendas-Baum R, Carson RT, Boer R, Tucker C, Andrae DA & Brazier JE (2016) Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D). Value in Health, Vol. 19(7) (pp A379-A379)
• King MT, Norman R, Viney R, Costa D, Brazier J, Cella D, Gamper E, Kemmler G, McTaggart-Cowan H, Peacock S , Pickard AS et al (2016) Two New Cancer-Specific Multi-Attribute Utility Instruments: EORTC QLU-C10D and FACT-8D. Value in Health, Vol. 19(7) (pp A807-A807)
• Brazier J, Mukuria CW, Peasgood T & Bjorner JB (2016) Well-Being: What Is It, How Does it Compare to Health and What are the Implications of Using it to Inform Health Policy?. Value in Health, Vol. 19(7) (pp A389-A389)
• Croudace T, Brazier J, Gutacker N, Street A, Robotham D, Waterman S, Rose D, Satkunanathan S, Wykes T, Nasr N , Enderby P et al (2016) Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Sheffield 2016: advances in patient reported outcomes research. Health and Quality of Life Outcomes, Vol. 14(Suppl 1), 9 June 2016 - 9 June 2016. View this article in WRRO
• Carlton J, Rowen D, Elliott J, Brazier J, Stevens K, Basarir H & Labeit A (2016) Developing a PROM to evaluate self-management in diabetes (HASMID): giving patients a voice. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14 View this article in WRRO
• Brazier J (2016) Well-being: what is it, how does it compare to health and what are the implications of using it to inform health policy. HEALTH AND QUALITY OF LIFE OUTCOMES, Vol. 14
• Rowen D, Labeit A, Brazier JE, Stevens K, Elliott J, Mulhern B, Carlton J, Basarir H & Meadows K (2016) Valuing the impact of self-management on quality of life in diabetes using discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 134-134)
• Bjorner JB, Croudace T, Keetharuth A, Brazier JE & Browne J (2016) Factor analyses identified one dominant global factor in a new scale for recovering quality of life (ReQoL) for mental health patients. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 95-95)
• Brazier JE, Keetharuth A, Connell J, Carlton J, Buck ET, Ricketts T & Barkham M (2016) First validation of the short recovering quality of life (ReQoL) measure. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 96-96)
• Keetharuth A, Brazier JE, Connell J, Carlton J, Ricketts T, Buck ET, Barkham M, Bjorner JB, Croudace T & Browne J (2016) Constructing the short recovering quality of life (ReQoL) measure for use in a mental health population: combining psychometric and qualitative evidence. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 70-70)
• Connell J, Brazier JE, Carlton J, Buck ET, Grundy A, Keetharuth A, Ricketts T & Barkham M (2016) Developing the recovery of quality of life measure (ReQoL): the views of mental health service users on potential items. QUALITY OF LIFE RESEARCH, Vol. 25 (pp 46-47)
• Patel PJ, Brazier J, Hirneiss C, Tangelder M & Lescrauwaet B (2016) Prevalence of Metamorphopsia in Patients with Vitreomacular Traction and its Impact on Quality of Life: The MeMo Study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 57(12)
• Brazier J, Keetharuth A, Connell J, Barkham M, Carlton J, Ricketts T & Taylor-Buck L (2016) Constructing Classification System For A New Qaly Measure In Mental Health: Recovering Quality Of Life (Reqol). Value in Health, Vol. 19(3) (pp A190-A190) View this article in WRRO
• Paul C, Barker J, Klekotka P, Milmont C, Viswanathan H, Nirula A, Brazier J, Harrison D, Mutebi A & Kricorian G (2016) Improvements in health-related quality of life measured by SF-36 and EQ-5D in patients with moderate to severe plaque psoriasis treated with brodalumab. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol. 74(5) (pp AB256-AB256)
• Brazier J, Hirneiß C, Tangelder M, Lescrauwaet B & Patel P (2016) Prevalence of Metamorphopsia in Patients with Vitreomacular Traction, with or without Macular Hole, and its Impact on Quality of Life: The Memo Study. Value in Health, Vol. 19(3) (pp A126-A126)
• Mulhern B, Norman R, Viney R, Lorgelly P, Lancsar E, Ratcliffe J & Brazier J (2016) VALUING EQ-5D-5L USING DISCRETE CHOICE EXPERIMENTS WITH DURATION: INVESTIGATING DIMENSION ORDER. Value in Health, Vol. 19(3) (pp A94-A94)
• Finch AP, Brazier J & Mukuria CW (2015) Validity and Responsiveness of Preference Based Measures: A Critical Overview of Reviews. Value in Health, Vol. 18(7) (pp A744-A744)
• Mukuria C, Brazier J & Peasgood T (2015) Does EQ-5D-5L account for the impact of limitations in activities of daily livings (ADLS) on social care outcomes, capabilities and well-being?. QUALITY OF LIFE RESEARCH, Vol. 24 (pp 179-179)
• Boegelund M, Feher M, Nikolajsen A, Vega-hernandez G & Brazier JE (2015) The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in North America. DIABETES, Vol. 64 (pp A349-A349)
• Feher M, Nikolajsen A, Vega-Hernandez G, Boegelund M & Brazier JE (2015) The Willingness to Pay for Improvements in Insulin Injectable Therapies for People with Type 2 Diabetes in the UK, France, and the Netherlands. DIABETES, Vol. 64 (pp A349-A349)
• Mukuria CW, Brazier J & Rafia R (2015) Does the generic cancer outcome measure eortc qlq-c30 work in myelofibrosis?. Value in Health, Vol. 18(3) (pp A210-A211)
• Costa D, King M, Aaronson N, Brazier J, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard S, Rowen D & Di Sipio T (2014) DO CANCER PATIENTS DISTINGUISH BETWEEN THE IMPORTANCE AND SEVERITY OF THEIR QUALITY OF LIFE CONCERNS?. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
• Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Fayers PM, Grimison P, Janda M, McTaggart-Cowan H, Norman R , Pallant J et al (2014) THE DEVELOPMENT OF CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENTS FROM THE EORTC QLQ-C30 AND FACT-G. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 10 (pp 31-31)
• Mukuria C & Brazier JE (2014) Health-related quality of life and well-being. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 62-62)
• Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard AS, Arbuckle R , Rowen D et al (2014) Do cancer patients distinguish between the importance and severity of their quality of life concerns?. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 122-122)
• Rowen D, Brazier JE, Keetharuth A, Tsuchiya A, Robinson A & Mukuria C (2014) Comparison of an online survey and face-to-face interviews for eliciting societal preferences. QUALITY OF LIFE RESEARCH, Vol. 23 (pp 49-49)
• Keetharuth A, Brazier J, Gibbons E, Ricketts T, Khan M, Connell J & Barkham M (2014) PROMs in Secondary Mental Health Services in the UK: a Feasibility Study and Lessons Learnt. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, Vol. 17 (pp S10-S10)
• Brazier JE, Connell J & O’Cathain A (2014) DO EQ-5D AND SF-6D ask the right questions in mental health? a content validation using interviews with patients. Value in Health, Vol. 17(3) (pp A194-A194)
• Tolley K, Miners A, Brazier J, Pericleous LM, Sharma T, Petersen J & Lonergan T (2013) THE USE OF PREFERENCE BASED MEASURES IN HAEMOPHILIA: IS THE CURRENT EVIDENCE BASE USEFUL FOR EVIDENCE BASED DECISION MAKING?. VALUE IN HEALTH, Vol. 16(7) (pp A386-A387)
• Wu M & Brazier J (2013) Examining the impact of EQ-5d and long-standing health conditions on subjective well-being.. Value Health, Vol. 16(3) (pp A26). United States
• Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, Ratcliffe J & Street DJ (2012) USING DISCRETE CHOICE EXPERIMENTS TO VALUE HEALTH STATES FOR ECONOMIC EVALUATION - THE SF-6D IN AUSTRALIA. VALUE IN HEALTH, Vol. 15(7) (pp A605-A606)
• King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella D, Fayers PM, Pallant JF, Peacock S, Pickard S, Rowen D , Velikova G et al (2012) THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 8 (pp 335-335)
• Jr LL, Yang Y, Brazier JE, Rowen D, Tsuchiya A & Young TA (2012) Valuing a vision 'bolt-on' item for the EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-54)
• Young TA, Rowen D, Mukuria C, Brazier JE & Jr LL (2012) Appropriate mapping functions in HRQL: a series of models mapping from FACT-G to EQ-5D. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 11-11)
• Mulhern B, Tsuchiya A, Brazier JE & Rowen D (2012) How do respondents perceive health state valuation tasks? A 'think aloud' study investigating time trade off and discrete choice experiments. QUALITY OF LIFE RESEARCH, Vol. 21 (pp 53-53)
• Palfreyman S & Brazier J (2012) THE DEVELOPMENT AND VALUATION OF THE SHEFFIELD PREFERENCE BASED LEG ULCER QUESTIONNAIRE (SPVU-5D). VALUE IN HEALTH, Vol. 15(4) (pp A126-A126)
• King M, Costa DSJ, Aaronson NK, Brazier J, Cella DF, Fayers P, Pallant JF, Peacock S, Pickard AS, Rowen D , Velikova G et al (2012) THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. VALUE IN HEALTH, Vol. 15(4) (pp A225-A225)
• Young TA, Brazier JE, Rowen D, Tsuchiya A & Yang Y (2012) The impact of adding a generic dimension to a condition-specific preference-based measure. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 10-10)
• Wong CKH, Lam CLK, Ma KP, McGhee SM, Law WL, Poon JTC, Chan P, Kwong DLW, Tsang J, Rowen DL & Brazier JE (2012) Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to Preference-based Values Measured by SF-6D in Patients with Colorectal Neoplasm. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 26-26)
• Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Pallant JS, Peacock S, Pickard S, Rowen D , Velikova G et al (2012) Adaptation of a method for developing a preference-based measure from a descriptive health-related quality of life measure (HRQOL): a confirmatory versus exploratory approach for the cancer-specific QLQ-C30. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 31-31)
• Rowen D, Brazier JE, Tsuchiya A, Young T & Ibbotson R (2012) The impact of condition labelling on health state utility values. QUALITY OF LIFE RESEARCH, Vol. 20 (pp 11-11)
• Ara R & Brazier J (2011) ARE GENERAL POPULATION DATA SUITABLE FOR APPROXIMATING BASELINE UTILITY VALUES IN ECONOMIC MODELS?. VALUE IN HEALTH, Vol. 14(7) (pp A428-A428)
• Peasgood T, Ward SE & Brazier J (2011) HEALTH STATE UTILITY VALUES IN BREAST CANCER: A REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A462-A462)
• Ara R & Brazier J (2011) ESTIMATING SF-6D HEALTH STATE UTILITY VALUES FOR COMORID HEALTH CONDITIONS. VALUE IN HEALTH, Vol. 14(7) (pp A427-A427)
• Papaioannou D, Peasgood T, Brazier J & Parry G (2011) THE VALIDITY OF THE EQ-5D, SF-6D, SF-36 AND SF-12 IN MENTAL HEALTH CONDITIONS: A SYSTEMATIC REVIEW. VALUE IN HEALTH, Vol. 14(7) (pp A239-A239)
• Meadows K, Mulhern B, Rowen D & Brazier J (2011) MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH. VALUE IN HEALTH, Vol. 14(7) (pp A242-A242)
• Brazier J, Rowen D, Tsuchiya A, Young T & Ibbotson R (2011) THE IMPACT OF CONDITION LABELLING ON HEALTH STATE VALUES. VALUE IN HEALTH, Vol. 14(7) (pp A457-A457)
• Ara R & Brazier J (2010) ESTIMATING HEALTH STATE UTILITY VALUES FOR COMORBID HEALTH CONDITIONS. VALUE HEALTH, Vol. 13(7) (pp A334-A335)
• Cruz LN, Camey SA, Hoffmann JF, Brazier J, Rowen D, Fleck MP & Polanczyk CA (2010) ESTIMATING THE SF-6D VALUE SET FOR A POPULATION BASED SAMPLE OF BRAZILIANS. VALUE HEALTH, Vol. 13(7) (pp A240-A240)
• Smith SC, Mulhern B, Brazier JE, Lamping DL, Knapp M, Rowen D, Loftus V & Banerjee S (2010) What do people with dementia and their proxies say about HRQL? A quantitative test of qualitative findings. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 14-14)
• Rowen D, Mulhern B, Brazier J, Jacoby A, Marson T, Latimer N, Snape D, Baker G & Hughes D (2010) Using the Liverpool Quality of Life battery to develop a health state classification system for Epilepsy. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 57-57)
• Mulhern BJ, Smith S, Brazier J, Rowen D, Lamping D, Knapp M, Loftus V & Banerjee S (2010) Developing a health state classification system for dementia using Rasch analysis. QUALITY OF LIFE RESEARCH, Vol. 19 (pp 35-36)
• Mutebi A, Brazier J & Walters S (2010) A COMPARISON OF THE DISCRIMINTATIVE AND EVALUATIVE PROPERTIES OF THE SF-36 AND THE SF-6D INDEX. VALUE HEALTH, Vol. 13(3) (pp A17-A17)
• Szende A, Brazier J, Schaefer C, Deuson R, Isitt J & Vyas P (2009) MEASUREMENT OF HEALTH UTILITY VALUES IN THE UK FOR HEALTH STATES RELATED TO IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA (ITP). VALUE HEALTH, Vol. 12(7) (pp A383-A383)
• Schwenkglenks M, Szucs TD, Brazier JE, Blackman DJ, Cyr P, Olchanski N & Stone GW (2009) COST-EFFECTIVENESS OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITOR IN THE TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION-A HORIZONS TRIAL ANALYSIS USING UK VALUATIONS. VALUE HEALTH, Vol. 12(7) (pp A334-A335)
• McTaggart-Cowan HM, Tsuchiya A, O'Cathain A & Brazier JE (2009) THE IMPACT OF DISEASE ADAPTATION ON GENERAL POPULATION VALUES. VALUE HEALTH, Vol. 12(3) (pp A35-A35)
• Yang Y, Brazier J, Tsuchiya A & Coyne K (2009) Estimating a preference-based single index from the overactive bladder questionnaire. Value in Health, Vol. 12(1) (pp 159-166)
• Tilling CJ, Krol M, Tsuchiya A, Brazier JE & Brouwer W (2008) IN OR OUT? EMPIRICAL EVIDENCE ON INCOME LOSSES IN HEALTH STATE VALUATIONS AND IMPLICATIONS FOR ECONOMIC EVALUATIONS. VALUE HEALTH, Vol. 11(6) (pp A563-A564)
• Ara R & Brazier JE (2008) Predicting a mean EQ-5D preference-based score from the 8 mean SF-36 dimension scores when individual data is not available. VALUE HEALTH, Vol. 11(3) (pp A178-A179)
• Ara R & Brazier JE (2008) Predicting SF-6D preference-based utilities using mean SF-36 health dimension scores when patient level data are not available. VALUE HEALTH, Vol. 11(3) (pp A178-A178)
• Cosstick R, Buckingham J, Brazier J & Fisher J (2007) Stabilization of multi-stranded nucleic acid structures using 3'-S-phosphorothiolate linkages.. Nucleosides Nucleotides Nucleic Acids, Vol. 26(6-7) (pp 555-558). United States
• Gaynor JW, Brazier J & Cosstick R (2007) Synthesis of 3'- S-phosphorothiolate oligonucleotides for their potential use in RNA interference.. Nucleosides Nucleotides Nucleic Acids, Vol. 26(6-7) (pp 709-712). United States
• Burness CE, Howlett S, Brazier J, Grunewald RA & Reuber M (2007) Outcome of tailored psychotherapy for nonepileptic seizures and other functional neurological symptoms. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 78(9) (pp 1016-1016)
• Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, Symmons D & Anis A (2007) Health state utility values in rheumatic diseases - A review. ANNALS OF THE RHEUMATIC DISEASES, Vol. 66 (pp 256-256)
• Holmes M, Brazier J, Tumur I, Ferriter M, Parry G, Dent-Brown K & Paisley S (2007) A probabilistic cost-effectiveness analysis of psychological therapies including dialectical behaviour therapy for borderline personality disorder.. J MENT HEALTH POLICY, Vol. 10 (pp S18-S19)
• Brazier J, Tumur I, Holmes M, Ferriter M, Dent-Brown K, Paisley S & Parry G (2007) Psychological therapies for borderline personality disorder: A systematic review. J MENT HEALTH POLICY, Vol. 10 (pp S5-S6)
• Ara RM & Brazier J (2006) Mapping generic quality of life measurements to disease specific variables in patients with Ankylosing Spondylitis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 273-273)
• Brazier JE, Yang Y, Tsuchiya A & Coyne K (2006) PUK11 ESTIMATING A PREFERENCE-BASED SINGLE INDEX FROM THE OVERACTIVE BLADDER QUESTIONNAIRE. Value in Health, Vol. 9(3) (pp A98-A98)
• Reeves P & Brazier JE (2006) Estimating a preference-based index from a condition specific measure - The King's Health Questionnaire. VALUE HEALTH, Vol. 9(3) (pp A97-A98)
• Brazier JE & Ratcliffe J (2005) ESTIMATING HEALTH STATE VALUATION MODELS FROM ORDINAL HEALTH STATE PREFERENCE DATA (RANK AND DISCRETE CHOICE EXPERIMENTS) AND COMPARING TO TTO VALUATIONS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2110-2110)
• Yang Y, Tsuchiya A, Brazier JE & Young TA (2005) ESTIMATING A PREFERENCE-BASED SINGLE INDEX FROM THE ASTHMA QUALITY OF LIFE QUESTIONNAIRE. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2012-2012)
• Young TA, Yang Y, Brazier JE & Tsuchiya A (2005) USING RASCH ANALYSIS TO AID THE CONSTRUCTION OF PREFERENCE BASED MEASURES FROM EXISTING QUALITY OF LIFE INSTRUMENTS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2081-2081)
• Marra CA, Coombes ME, Moadebi S, Yeh E, FitzGerald JM, Elwood K, Brazier JE & Marra F (2005) COMPARISON OF THE HUI-3 AND SF-6D IN PATIENTS WITH LATENT AND ACTIVE TUBERCULOSIS. QUALITY OF LIFE RESEARCH, Vol. 14(9) (pp 2020-2020)
• Gray DT, Walters S, Spertus J, Brazier J & Horvath K (2005) Quality-adjusted survival and cost-effectiveness of transmyocardial revascularization using the CO2 laser. CIRCULATION, Vol. 111(20) (pp E319-E319)
• Palfreyman SJ, Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Ratcliffe J & Rigby K (2005) A prospective clinical trial of the management and outcome of uncomplicated varicose veins. BRITISH JOURNAL OF SURGERY, Vol. 92(4) (pp 506-506)
• Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J & Rigby K (2005) Randomized trial of treatment for uncomplicated varicose veins: surgery is clinically and cost effective. BRITISH JOURNAL OF SURGERY, Vol. 92(4) (pp 506-507)
• Ratcliffe J, Brazier J, Palfreyman S & Michaels J (2004) An exploration of the discrepancies between health state valuations of patients and the general population. VALUE HEALTH, Vol. 7(6) (pp 775-775)
• Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A & Anis AH (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. MEDICAL CARE, Vol. 42(11) (pp 1125-1131)
• Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and teriparatide in women with a prior fracture, low BMD and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S39)
• Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D in women with low dietary calcium intake. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S39-S40)
• Brazier JE, Ratcliffe J, Michaels J & Palfreyman S (2004) COMPARISON OF PATIENT AND GENERAL POPULATION VALUES: THE CASE OF VARICOSE VEINS. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1557-1557)
• Murray CJC, Brazier J, Espallargues M & Bansback N (2004) A COMPARISON OF PREFERENCE-BASED MEASURES IN PATIENTS WITH AGE RELATED MACULAR DEGENERATION. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1509-1509)
• Brazier JE (2004) PATIENT INVOLVEMENT IN VALUING HEALTH STATES FOR USE IN ECONOMIC EVALUATION. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1571-1571)
• Lam CL, Brazier J & McGhee SM (2004) PILOT TEST OF SF-6D VALUATION SURVEY ON CHINESE ADULTS IN HONG KONG. QUALITY OF LIFE RESEARCH, Vol. 13(9) (pp 1509-1509)
• Stevenson MD, Brazier JE, Lloyd-Jones M, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and hormone replacement therapy in women with established osteoporosis and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S111-S111)
• Stevenson MD, Lloyd-Jones M, Brazier JE, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D supplementation in women with low dietary intake of these nutrients and at risk of osteoporosis. OSTEOPOROSIS INTERNATIONAL, Vol. 15 (pp S87-S88)
• Brazier JE, Zoellner YF, Platts M & Towers I (2003) Developing a preference-based measure for postmenopausal health. VALUE HEALTH, Vol. 6(6) (pp 606-606)
• McCloskey E, Jalava T, Oden A, Johansson H, Kayan K, Beneton M, Brazier J, Nicholl J, Richards A, Cliffe J , Reaney L et al (2003) The efficacy of clodronate (Bonefos (R)) to reduce the incidence of osteoporotic fractures in elderly women is independent of the underlying BMD.. JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 18 (pp S92-S92)
• Smith S, Brazier JE, Parry G & Edbrooke DL (2003) SF-36 and EQ-5D in adult ICU patients. INTENSIVE CARE MEDICINE, Vol. 29 (pp S176-S176)
• Fry AM, Round A, Stein K, Brazier J & Milne R (2003) Justifying the development of a lay panel to produce utilities for use in health technology assessments (HTAS): Review of current issues,and views of technology appraisal committee members. VALUE HEALTH, Vol. 6(3) (pp 305-305)
• Marra CA, Woolcott J, Offer R, Guh D, Brazier JE, Esdaile JM & Anis AH (2002) A within subject comparison of four indirect utility measures in rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S74-S74)
• Marra CA, Woolcott J, Shojania K, Brazier JE, Esdaile JM & Anis AH (2002) Comparison of health state utilities using community and patient preference weights derived from a survey of patients with rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S74-S74)
• Stevenson MD, Brazier JE, Kanis J & Lloyd-Jones M (2000) Cost-effectiveness of current treatments for established female osteoporosis. OSTEOPOROSIS INT, Vol. 11 (pp S11-S11)
• deTakats D, McCloskey E, Bernard J, Orgee J, Coombes G, Khan S, Nicholl J, Brazier J, Beneton M, Charlesworth D & Kanis J (1997) Effects of clodronate on hip BMD in community-dwelling women: Randomised trial: 1 year results.. J BONE MINER RES, Vol. 12 (pp S490-S490)
• MCCLOSKEY E, KHAN S, ORGEE J, COOMBES G, TAUBE T, PHILLIPS R, BRAZIER J, NICHOLL J & KANIS J (1995) ORAL CLODRONATE PREVENTS BONE LOSS AT THE HIP IN ELDERLY WOMEN - A PILOT-STUDY. J BONE MINER RES, Vol. 10 (pp S356-S356)
• AARONSON NK, ACQUADRO C, ALONSO J, APOLONE G, BECH P, BRAZIER J, BULLINGER M, FUKUHARA S, GANDEK B, KAASA S , KELLER S et al (1994) TRANSLATING HEALTH - THE INTERNATIONAL QUALITY-OF-LIFE ASSESSMENT (IQOLA) PROJECT. QUAL LIFE RES, Vol. 3(1) (pp 66-66)
• WARE JE, KELLER S, BENTLER PM, SULLIVAN M, BRAZIER J & GANDEK B (1994) COMPARISON OF HEALTH-STATUS MEASUREMENT MODELS AND THE VALIDITY OF SF-36 IN GREAT-BRITAIN, SWEDEN AND THE USA. QUAL LIFE RES, Vol. 3(1) (pp 68-68)
• Czoski-Murray C, Carlton C, Young T, Brazier J, Papo N & Kwon Kang H () Health state valuation for ARMD visual impairment states using simulation lenses. 6th iHEA World Congress on Health Economics. Copenhagen, Denmark, July 2007.
• Brazier J, Tsuchiya A & Yang Y () A Condition-Specific Preference-Based Instrument: The Asthma Quality of Life Utility Index (AQL-5D)

Reports

• Keetharuth D, Rowen D, Bjorner JB & Brazier J (2020) Estimating a Preference-Based Index for mental health from the Recovering Quality of Life (ReQoL) measure: Valuation of ReQoL-UI View this article in WRRO
• Rowen D, Brazier J, Wong R & Wailoo A (2020) Measuring and valuing health-related quality of life when sufficient EQ-5D data is not available
• Rowen D, Keetharuth D, Poku E, Wailoo A, Wong R, Pennington R & Brazier J (2019) A review of the psychometric performance of paediatric preference-based measures used to generate utility values for children
• Mukuria C, Rowen D, Peasgood T & Brazier JE (2016) An empirical comparison of well-being measures used in the UK View this article in WRRO
• Karimi M, Brazier J & Basarir H (2016) The Capability Approach: A Critical Review of Its Application in Health Economics View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE View this article in WRRO
• Ara , Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer. View this article in WRRO
• Keetharuth D, Mulhern B, Wong R, Ara R, Franklin M, Jones G & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audit Work Package 2. How should PROMS data be collected? View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. View this article in WRRO
• peasgood T, Brazier JE, mukuria C & Rowen D (2014) A conceptual comparison of well-being measures used in the UK. View this article in WRRO
• Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 1, Executive summary, introduction, clinical reviews and conceptual modelling.
• Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 2. Independent economic evaluation: methods and results, discussion and conclusion
• Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Appendices.
• Rowen D, Brazier J, Mukuria C, Keetharuth A, Rise Hole A, Tsuchiya A, Whyte S & Shackley P (2014) Update: Eliciting societal preferences for weighting QALY's according to burden of illness, size of gain and end of life View this article in WRRO
• Ara R, Kearns B, Mukuria C, van Hout B & Brazier JE (2013) Examining productivity losses associated with health related quality of life using patient and general population data. View this article in WRRO
• Whyte S, Brazier J, Rowen D, Mukuria C, Keetharuth A, RiseHole A, Tsuchiya A & Shackley P (2013) Eliciting societal preferences for burden of illness, therapeutic improvement and end of life for value based pricing: a report of the main survey View this article in WRRO
• ara R, van hout B, Kearns B & Brazier JE (2013) Case-mix methodology for the NHS outcomes framework GP Patient Survey Questionnaire Data View this article in WRRO
• Ara R, Keetharuth D, Papaioannou D, Cantrell A & Brazier JE (2011) Evaluating public health interventions for obesity from the perspective of local health authorities. View this article in WRRO
• Parry G, Barkham M, Brazier J, Dent-Brown K, Hardy G, Kendrick T, Rick J, Chambers E, Chan T, Connell J , Hutten R et al (2011) An evaluation of a new service model: Improving Access to Psychological Therapies demonstration sites 2006-2009. Final report. NIHR Service Delivery and Organisation programme View this article in WRRO
• Hutten R, Parry GD, Barkham , Brazier , Dent-Brown , Hardy , Rick J, Chambers , Connell , de Lusignan S , Mukuria et al (2011) An evaluation of a new service model: Improving Access to Psychological Therapies demonstration sites 2006-2009, Final Report. View this article in WRRO
• Brazier J & Rowen D (2011) NICE DSU Technical Support Document 11: Alternatives to EQ-5D for generating health state utility values

Scholarly editions

• Mulhern B, Rowen D, Brazier J, Jacoby A, Marson T, Snape D, Hughes D, Latimer N & Baker GA (2010) Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report.
• Brazier J, Rowen D, Yang Y & Tsuchiya A (2009) Using rank and discrete choice data to estimate health state utility values on the QALY scale.
• McTaggart-Cowan H, O'Cathain A, Tsuchiya A & Brazier J (2009) A qualitative study exploring the general population’s perception of rheumatoid arthritis after being informed about disease adaptation.
• Rowen D, Brazier J, Tsuchiya A, Hernández M & Ibbotson R (2009) The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results.
• McTaggart-Cowan H, Brazier J & Tsuchiya A (2008) Combining Rasch and cluster analysis: a novel method for developing rheumatoid arthritis states for use in valuation studies.
• Peasgood T, Brazier J & Ward S A review and meta-analysis of health state utility values in breast cancer.
• Tappenden P, Brazier J & Ratcliffe J Does the National Institute for Health and Clinical Excellence take account of factors such as uncertainty and equity as well as incremental cost-effectiveness in commissioning health care services? A binary choice experiment.

Posters

• Schneider P, van Hout B, Heisen M, Brazier JE & Devlin N (2022) P60 A New Online Tool for Valuing Health States: Eliciting Personal Utility Functions for the EQ-5D-5L.
• Mukuria C, Peasgood T, Brazier J, Rowen D & Norman R (2020) E-QALY: valuing the items for a new generic preference-based measure using time trade-off and discrete choice experiments.
• Rees A, Paisley S, Brazier J, Cantrell A, Poku E & Williams K (2013) DEVELOPMENT OF THE SCHARR HUD (HEALTH UTILITIES DATABASE).
• Keetharuth A, Rowen D, Bjorner J & Brazier J Estimating a Preference-Based Index from the Recovering Quality of Life measure for economic evaluation in the area of mental health: Valuation of ReQoL-UI.
• Brazier J, Keetharuth A, Connell J, Carlton J, Buck ET, Ricketts T & Barkham M Constructing a classification system for a new QALY measure in mental health: recovering quality of life (ReQoL).
• Brazier J, Keetharuth A, Connell J, Barkham M & Ricketts T ReQoL: Recovering Quality of LIfe.
• Connell J, Brazier J & Keetharuth A Development of the Recovering Quality of Life Measure (2014).
• Brazier J, Keetharuth A, Connell J, Carlton J, Ricketts T, Buck ET & Barkham M First validation of the Recovering Quality of Life measures: a new PROM for use in mental health.
• Mukuria C, Brazier J & Rafia R Does the generic cancer outcome measure EORTC QLQ-C30 work in Myelofibrosis? (ISPOR 20th Annual International Meeting 16-20 May 2015).
• Palfreyman S & Brazier J Development of a preference-based, condition specific patient reported outcome measure for use with venous ulceration (2012).
• Wu M, Brazier J, Blackburn J, Cooper CL, Relton C & Smith C Examining the incremental impact of long-standing health conditions on subjective well-being – is there anything missing from the EQ-5D? (ISPOR 18th Annual International Meeting 18-22 May 2013).
• Ara R & Brazier J Are general population data suitable for approximating baseline utility values in economic models?.
• Finch AP, Brazier J & Mukuria C Selection of bolt-ons after factor analysis identification: are linear regression models a useful technique?.
• Keetharuth D, Connell J, Karimi M, Barkham M, Ricketts T & Brazier J ReQol - Recovering Quality of Life (Quality in Mental Health Conference 23 March 2015).
• Brazier J, Rowen D, Tsuchiya A, Young T & Ibbotson R The impact of conditions labels on health state values.
• Ara R & Brazier J Estimating SF-6D health state utility values for comorbid health conditions.
• Brazier J & Sculpher M Policy Research Unit in Economic Evaluation of Health and Care Interventions.

Datasets

• Pennington R, Hernandez M, Hykin P, Sivaprasad S, Flight L, Alshreef A & Brazier J Utility calculator for visual acuity.
• Powell P, Carlton J, Rowen D & Brazier J Psychometric data for 'A new quality of life questionnaire for use in Duchenne muscular dystrophy: the DMD-QoL'.
• Powell P, Carlton J, Rowen D & Brazier J Supplementary files for 'A new quality of life questionnaire for use in Duchenne muscular dystrophy: the DMD-QoL'.

Presentations

• Ratcliffe J, Chen G, Huynh E, Xu F, Stevens K, Brazier J & Swait J OP55 Health Technology Assessment In Children And Adolescents: Adolescent Preferences For Child Health Utility 9D Health States.

Other

• Brazier J, Peasgood T, Mukuria C, Luo N, Mulhern B, Pickard AS, Augustovski F, Greiner W & Engel L (2022) Author Reply. Value in Health.
• Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2017) Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 26(8), 2247-2248. View this article in WRRO
• Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS , Rowen D et al (2016) Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, 25(9), 2401-2401.
• King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R , Pickard AS et al (2016) Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of Life Research, 25(10), 2683-2683.
• Lu G, Brazier JE & Ades AE (2013) Rejoinder to commentary: When mapping treatment effects from disease-specific to generic scales, ordinary least squares regression underestimates the benefits of treatment. Value in Health, 16(1), 217-218.
• Brazier J (2010) Is the EQ-5D fit for purpose in mental health?. BRIT J PSYCHIAT, 197(5), 348-349.
• Rowen D, Carlton J, Brazier JE, Mulhern B, Palfreyman S, Stevens K & Tsuchiya A (2010) FDA on PROMs: Two important points. BMJ (Online), 341(7776), 746.
• Stevens K, McCabe C & Brazier J (2007) It might be premature to reject the assumption of a power curve relationship between VAS and SG data: three comments on Stevens, McCabe and Brazier's 'mapping between VAS and SG data; results from the UKHUI index 2 valuation survey' - Response. HEALTH ECON, 16(7), 759-761.
• Brazier J & McCabe C (2007) 'Is there a case for using visual analogue scale valuations in CUA' by Parkin and Devlin. A response: 'yes there is a case, but what does it add to ordinal data?'.. Health Econ, 16(6), 645-647.
• Parsons HK, Tomlin K, Metcalf SC, Brazier JE & Dockrell DH (2006) The economic cost of invasive pneumococcal disease and the potential for reduction by vaccination in an adult population in South Yorkshire.. QJM, 99(5), 348-349.
• Stevens KJ, McCabe CJ & Brazier JE (2006) Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey.. Health Econ, 15(5), 527-533.
• Harper R, Brazier J & Waterhouse J (1998) Comparison of outcome measures in patients with COPD - Reply. THORAX, 53(9), 813-813.
• BRAZIER J (1995) HEALTH-STATUS MEASUREMENT - A PERSPECTIVE ON CHANGE - BROOKS,RG. HEALTH ECON, 4(2), 149-150.
• LOWY A, FALL M & BRAZIER J (1993) SKIN BIOPSIES BY GPS. BRIT J GEN PRACT, 43(376), 478-478.
• NICHOLL JP & BRAZIER JE (1993) LAPAROSCOPIC VERSUS MINI-INCISION CHOLECYSTECTOMY. LANCET, 341(8836), 47-47.
• Nicholl J, Brazier JE & Williams BT (1993) Management of trauma [20]. British Medical Journal, 307(6905), 683-684.
• BRAZIER J, HARPER R, JONES N, THOMAS K, WESTLAKE L & USHERWOOD T (1992) VALIDATING THE SF-36 - REPLY. BRIT MED J, 305(6854), 646-646.
• BRAZIER JE & LOWY A (1991) PERFORMANCE OF SKIN BIOPSIES BY GENERAL-PRACTITIONERS. BRIT MED J, 303(6815), 1472-1472.
• GEORGE SL & BRAZIER JE (1990) CASELOAD OR WORKLOAD. BRIT MED J, 301(6751), 556-556.
• PITT FA & BRAZIER J (1990) HORMONE REPLACEMENT THERAPY FOR OSTEOPOROSIS. LANCET, 335(8695), 978-978.
• PAGE H & BRAZIER J (1989) BENEFITS OF INVITRO FERTILIZATION. LANCET, 2(8675), 1327-1328.
• Alshreef A, Brazier J, Poku E, Hykin P & Sivaprasad S () LEAVO Health Economic and Decision Modelling Analysis Plan (HEDMAP).

Preprints

• Durno N, Zormpas E, Schmid R, Heisen M, Hartl K, Ethgen O, Szilvasy Z, Friedel E, Wong O, Charman T , Cáceres ASJ et al () Health Preferences in Childhood Autism Spectrum Disorder (ASD): A Discrete Choice Experiment using the Childhood Autism Rating Scale (CARS2), Research Square Platform LLC.
• Hartl K, Durno N, Schmid R, Heisen M, Ethgen O, Szilvasy Z, Friedel E, Wong O, Charman T, Cáceres ASJ , Mühlbacher A et al () Feasibility Assessment of a Health Preference Study in Autism Based on the Childhood Autism Rating Scale (CARS2): A Qualitative Study with Clinicians and Caregivers, Research Square Platform LLC.
• Acaster S, Mukuria C, Rowen D, Brazier JE, Wainwright CE, Quon BS, Duckers J, Quittner AL, Lou Y, Sosnay P & McGarry LJ () Development of the CFQ-R-8D: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised, Research Square Platform LLC.
• Tilling CJ, Krol M, Attema AE, Tsuchiya A, Brazier J, van Exel J & Brouwer W () Exploring a New Method for Deriving the Monetary Value of a QALY.
• Brazier J, Yang Y & Tsuchiya A () A New Method for Using Rank and Discrete Choice Data to Estimate Health State Utlity Values for QALYs: The Case of the AQL-5D.
• Mukuria C, Peasgood T & Brazier J () Applying EuroQol Portable Valuation Technology to the EQ Health and Wellbeing Short (EQHWB-S): a pilot study. View this article in WRRO